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ABSTRACT OF THE DISSERTATION 
 
The Nrl Photoreceptor Cell Fate Switch: Endogenous Regulation and Therapeutic 
Applications 
by 
Cynthia Lee Montana 
Doctor of Philosophy in Biology & Biomedical Sciences 
Molecular Cell Biology 
 
Washington University in St. Louis, 2014 
Professor Joseph Corbo, Chairperson 
 
The transcription factor neural retina leucine zipper (Nrl) is a critical determinant of rod 
photoreceptor fate and a key regulator of rod differentiation.  Nrl-/- rod precursors fail to 
turn on rod genes and instead differentiate as cones.  Furthermore, NRL mutations in 
humans cause retinitis pigmentosa, a potentially debilitating disease.  Despite the 
developmental and clinical significance of this gene, however, little is known about the 
transcriptional regulation of Nrl itself.  In this study, we sought to define the cis- and 
trans-acting factors responsible for initiation and maintenance of Nrl transcription in the 
mouse retina.  Utilizing a quantitative mouse retinal explant electroporation assay, we 
discovered a phylogenetically conserved, 30-base pair region immediately upstream of 
the transcription start site that is required for Nrl promoter activity.  This region contains 
critical binding sites for the retinal transcription factors Crx, Otx2, and RORβ, and 
experiments demonstrate binding of these factors both in vitro and in vivo.  We propose a 
 xi
model in which Nrl expression is primarily initiated by Otx2 and RORβ and later 
maintained at high levels by Crx and RORβ. 
 In addition to elucidating the developmental regulation of Nrl, we sought to 
determine whether manipulation of this photoreceptor cell fate switch might be 
applicable to the treatment of heritable blindness.  Retinitis pigmentosa is one of the most 
common degenerative diseases of the eye and is associated with early rod photoreceptor 
death followed by secondary cone degeneration.  We hypothesized that converting adult 
rods into cones would make the cells resistant to the effects of mutations in rod-specific 
genes, thereby preventing secondary cone loss.  To test this idea, we engineered a 
tamoxifen-inducible allele of Nrl to acutely inactivate the gene in adult rods.  This 
manipulation resulted in reprogramming of rods into cells with cone-like molecular, 
histologic and functional properties.  Moreover, reprogramming of adult rods achieved 
cellular and functional rescue of retinal degeneration in a mouse model of retinitis 
pigmentosa.  These findings suggest that elimination of Nrl in adult rods may represent a 
novel therapy for retinal degeneration. 
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CHAPTER 1 
 
 
Introduction to retinal development, neural retina 
leucine zipper (Nrl), and somatic cell 
reprogramming 
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1.1 The retinal progenitor cell and fate specification 
 
The sense of sight is an ancient and important adaptation for many animal species.  The 
molecular pathways for light perception have evolved steadily over the past 600 million 
years, from the light-sensitive pigments of cnidarians (Plachetzki et al., 2007) to the 
complex neural interface of vertebrates.  Scientists have turned to many model systems to 
study the visual system, including the rodent, chicken, zebrafish, frog, salamander, and 
even jumping spider.  Visual perception in these animals begins with the retina, a light-
sensitive neural tissue at the back of the eye.  The vertebrate retina contains six neuronal 
and one glial cell type organized into distinct layers.  Rod and cone photoreceptors, 
residing in the outer nuclear layer (ONL), detect photons and convert light input into 
chemical output.  Horizontal cells, bipolar cells, and amacrine cells, residing in the inner 
nuclear layer (INL), integrate the photoreceptor output and transmit the signal to retinal 
ganglion cells in the ganglion cell layer (GCL).  Retinal ganglion cells then relay the 
partially processed visual information to the brain via the optic nerve. 
 
The multi-potent retinal progenitor cell 
The beautifully laminar structure of the vertebrate retina, as well as characteristic 
morphological features of the various retinal cell types (Cajal, 1893), have facilitated 
rigorous cell birthdating studies that form the groundwork for the study of retinal 
development (Carter-Dawson and LaVail, 1979b; Young, 1985).  Classic H3-thymidine 
labeling experiments have established the order of retinal cell differentiation in the 
mouse:  most retinal ganglion cells, horizontal cells, amacrine cells, and cone 
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photoreceptors are born prenatally, while bipolar cells and Müller glia are born 
postnatally.  The window of rod photoreceptor birth extends from embryonic day 12 
(E12) through postnatal day 11 (P11), with the peak of differentiation occurring around 
P0 (Young, 1985).  For both rods and cones, cell birth in the central retina precedes that 
in the peripheral retina by two to three days (Carter-Dawson and LaVail, 1979b). 
 The progressive generation of retinal cell types gives rise to a fundamental 
question:  does a common, multi-potent progenitor cell produce all cell types, or is the 
fate of a given progenitor restricted to a subset of cell type(s)?  Several elegant studies 
indicate that retinal progenitor cells are indeed competent to produce all retinal cell types.  
In experiments conducted in the chicken, rat, mouse, and frog, single embryonic 
progenitor cells were labeled by either replication-incompetent retroviral vectors (Fekete 
et al., 1994; Turner and Cepko, 1987; Turner et al., 1990) or cellular injection (Holt et al., 
1988; Wetts and Fraser, 1988).  Following the completion of retinal development, the 
labeled progenitors were found to have given rise to various combinations of all retinal 
cell types. 
 
The competence model of retinal cell fate specification 
Given that cycling progenitor cells are multi-potent, what factors then specify the fate of 
post-mitotic daughter cells?  Evidence from many experiments in different model 
systems supports the ‘competence model’ of retinal cell fate specification that 
incorporates both intrinsic and extrinsic cues (reviewed in Cepko et al., 1996; Livesey 
and Cepko, 2001).  In this model, cycling progenitors pass through temporal stages 
during which they are able, or competent, to produce only a subset of retinal cell types.  
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These competence stages are likely defined by intrinsic variables such as the expression 
of specific transcription factors.  The type of cell produced during a particular 
competence stage, on the other hand, is likely influenced by extrinsic factors such as 
protein ligands and small molecules.  This model was established in large part by 
heterochronic experiments, where labeled embryonic cells (E15 or E16) were 
transplanted into cultures of postnatal cells (P0 or P1) (Belliveau and Cepko, 1999; 
Watanabe and Raff, 1990).  The postnatal environment was able to increase the number 
of rods eventually produced from the embryonic cells, but not the number of other 
postnatally born cell types such as bipolar cells and Müller glia.  Conversely, late 
progenitor cells could not be induced efficiently in culture to adopt the fate of early-born 
retinal ganglion cells (Austin et al., 1995).   
 Retinal culture systems have also been used to study the effects of specific 
extrinsic factors on differentiation.  Application of the cytokine CNTF to explanted rat 
retinas, for example, causes rod photoreceptor precursors to instead differentiate as 
bipolar cells (Ezzeddine et al., 1997).  Alternatively, a number of soluble molecules have 
been shown to promote rod photoreceptor differentiation, including taurine (Altshuler et 
al., 1993; Young and Cepko, 2004), retinoic acid (Hyatt et al., 1996; Kelley et al., 1994; 
Kelley et al., 1999; Osakada et al., 2008), and sonic hedgehog protein (Levine et al., 
1997; Stenkamp et al., 2000).  Thus, the integration of intrinsic and environmental inputs 
specifies the fate of post-mitotic retinal precursor cells. 
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1.2 bHLH and homeodomain transcription factors in photoreceptor 
differentiation 
 
Advances in transgenesis have greatly increased our understanding of specific signaling 
pathways and transcription factors involved in retinal development.  The roles of Notch 
signaling (Perron and Harris, 2000), bHLH activators and repressors (Cepko, 1999; 
Hatakeyama and Kageyama, 2004; Yan et al., 2005), and homeodomain transcription 
factors (Hennig et al., 2008; Swaroop et al., 2010) have been particularly well studied.  In 
general, Notch signaling activates the repressor bHLH factors Hes1 and Hes2, which 
maintain the progenitor state by suppressing the transcription of proneural bHLH factors.  
Upon cessation of Notch signaling, proneural bHLH transcription factors such as Math5, 
NeuroD, and Mash1 promote exit from the cell cycle and terminal differentiation (Jadhav 
et al., 2006b; Riesenberg et al., 2009; Yaron et al., 2006).   
 The importance of Notch signaling in murine retinal development has been 
confirmed by both loss- and gain-of-function experiments.  Early deletion of Notch1 in 
the mouse retina causes a large proportion of progenitor cells to differentiate prematurely 
as cones, whereas later deletion results in overproduction of rods (Jadhav et al., 2006b).  
Conversely, constitutive activation of the Notch pathway maintains the progenitor 
population and eventually promotes glial and stem cell-like phenotypes in the adult retina 
(Jadhav et al., 2006a).  These results are in agreement with the competence model of 
retinal differentiation (Cepko et al., 1996) and suggest an important role for downstream 
bHLH factors in specifying retinal cell fate.  
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 The interactions between proneural bHLH factors and other transcription factors 
in the developing retina are complex, although a simplified model has been proposed 
(Hatakeyama and Kageyama, 2004).  In this model, homeodomain transcription factors 
specify the retinal cell layer for a given precursor, and bHLH factors specify the neuronal 
fate within the layer.  Bipolar cells, for example, are directed to develop in the INL by the 
homeodomain factor Chx10 (Burmeister et al., 1996; Hatakeyama et al., 2001), but 
bipolar cell fate in particular is determined by the bHLH factors Mash1 and Math3 
(Hatakeyama et al., 2001).  The remainder of this discussion will concentrate on the role 
of transcription factors specifically in photoreceptor differentiation (Fig. 1.1) 
 
bHLH factors and photoreceptor specification 
NeuroD is the best-studied bHLH factor implicated in photoreceptor differentiation, but 
its precise actions during development are somewhat species-specific.  In the chicken, 
NeuroD appears to direct photoreceptor fate:  suppression of NeuroD causes loss of 
photoreceptor development (Yan and Wang, 2004), while overexpression in the retinal 
neuroepithelium results in excess photoreceptors (Yan and Wang, 1998).  The role of 
NeuroD in the mouse retina is somewhat more complicated.  NeuroD1 appears to specify 
amacrine fate at the expense of bipolar cells (Morrow et al., 1999) but is also important 
for long-term photoreceptor survival (Morrow et al., 1999; Pennesi et al., 2003).  Other 
NeuroD family members play yet other roles in retinal development (Cherry et al., 2011). 
 There is limited evidence for the direction of photoreceptor fate by additional 
bHLH proteins such as Mash1 (Ahmad, 1995), Ngn1 (Yan et al., 2010), Ngn2 (Yan et al., 
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2001), and Math5 (Brown et al., 1998; Le et al., 2006), but further studies will be 
required to elucidate the precise roles of these factors in photoreceptor differentiation. 
 
Orthodenticle homeobox 2 (Otx2) 
Notch-Hes signaling is thought to directly regulate the expression of Otx2 (Muranishi et 
al., 2011), a bicoid class homeobox transcription factor required for the development of 
the forebrain (Acampora et al., 1995; Ang et al., 1996; Matsuo et al., 1995).  During 
embryogenesis, Otx2 expression is widespread in the epiblast but eventually becomes 
restricted to the forebrain and midbrain (Simeone et al., 1993).  In the developing retina, 
Otx2 expression is dynamic:  at embryonic timepoints (E12.5-E17.5) it is expressed 
strongly in the retinal pigment epithelium (RPE) and outer neuroblastic layer, which 
eventually gives rise to the photoreceptors in the ONL.  Postnatally, however, Otx2 is 
downregulated in the ONL and upregulated in bipolar cells of the INL (Fossat et al., 
2007; Nishida et al., 2003). 
 Functionally, expression of Otx2 in the final cell cycle of retinal progenitor cells 
is thought to signal commitment to the photoreceptor cell fate (Muranishi et al., 2011).  
Otx2 is necessary for photoreceptor development:  photoreceptor precursors in the Otx2 
null retina instead develop as amacrine-like neurons (Nishida et al., 2003).  Otx2 is also a 
regulator of photoreceptor genes during early development, including the transcription 
factor Crx (Nishida et al., 2003) and other genes such as Rho, Pde6b, and Sag (Koike et 
al., 2007).   
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Cone-rod homeobox (Crx) 
Crx is another homeobox transcription factor that acts immediately downstream of Otx2 
to regulate the differentiation of both rod and cone photoreceptors (Chen et al., 1997; 
Freund et al., 1997; Furukawa et al., 1997).  Photoreceptors develop in the Crx null 
retina, but they fail to adequately express a large cohort of rod- and cone-specific genes, 
lack outer segments and light responsiveness, and eventually degenerate (Furukawa et al., 
1999).  Traditional ChIP (Hennig et al., 2008; Peng and Chen, 2005) and ChIP-seq 
studies (Corbo et al., 2010) suggest that Crx is a master regulator of nearly all 
photoreceptor genes, binding directly to promoter and enhancer regions to activate 
transcription.  In the developing retina, Crx is thought to regulate many genes 
coordinately with Otx2 (Koike et al., 2007), as the two transcription factors have nearly 
identical DNA binding domains (Chen et al., 1997; Furukawa et al., 1997) and DNA 
binding preferences (Chatelain et al., 2006; Lee et al., 2010). 
 Unsurprisingly, mutations in human CRX result in a variety of retinal disease, 
including Leber congenital amaurosis, cone-rod degeneration, and retinitis pigmentosa 
(Freund et al., 1997; Rivolta et al., 2001).  Many disease alleles are dominant, and the 
pathogenic mechanism of various mutations is the subject of ongoing research. 
 
1.3 Nrl and the specification of rod photoreceptor fate 
 
The final stage of photoreceptor differentiation is commitment to either the rod or cone 
lineage.  A single transcription factor, Nrl, has been identified in the mouse as a ‘cell fate 
switch’ between the rod and cone phenotypes:  photoreceptor precursors that turn on Nrl 
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become rods, and those that do not become cones.  The nature of this switch was 
elucidated by the Nrl knockout mouse, which exhibits en masse conversion of all rod 
photoreceptor precursors into blue cones (Akimoto et al., 2006; Mears et al., 2001).  
These reprogrammed cones are fully functional and cause a phenotype similar to human 
enhanced S-cone syndrome, with increased sensitivity to blue light (Daniele et al., 2005; 
Haider et al., 2000).  The all-cone, Nrl mutant retina experiences an early period of 
photoreceptor cell death and inflammation, but degeneration ceases by 4 months and the 
ONL is largely intact out to 10 months of age (Roger et al., 2012).  
 Nrl is not only necessary but also sufficient for rod photoreceptor specification.  
Ectopic Nrl expression in all photoreceptors of wild-type and Nrl-/- mice, driven by the 
Crx promoter, results in functional all-rod retinas (Oh et al., 2007).  The temporal 
window for transformation of cone precursors into rods is limited, however, as ectopic 
Nrl expression driven by the later-acting S-opsin promoter results in hybrid 
photoreceptors expressing both rod and cone genes (Oh et al., 2007). 
 
Regulation of Nrl expression 
Nrl transcripts are first detectable in the developing retina at E12 (Akimoto et al., 2006), 
coincident with the beginning of the rod photoreceptor birth period (Carter-Dawson and 
LaVail, 1979b; Young, 1985).  Nrl expression localizes to the outer neuroblastic layer of 
the developing retina (Akimoto et al., 2006; Montana et al., 2011), and BrdU studies in 
the pNrl-GFP transgenic mouse suggest that Nrl is turned on in a subset of photoreceptor 
precursors shortly after the terminal mitosis (Akimoto et al., 2006).  In adult mice the Nrl 
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transcript localizes to the ONL (Hsiau et al., 2007), and antibody staining indicates that 
the protein is restricted to the nuclei of rods but not cones (Swain et al., 2001). 
 While the rod-specific Nrl expression pattern has been well characterized, the 
transcriptional mechanisms underlying this pattern were, up to now, largely unknown.  
The core Nrl promoter has been identified as either a 3.2-kb (Matsuda and Cepko, 2004) 
or 2.5-kb (Akimoto et al., 2006) region immediately upstream of the first exon.  One 
study of this region identified discrete binding sites for retinoic acid receptors (Khanna et 
al., 2006), possibly explaining why retinoic acid is a strong inducer of rod differentiation 
(Hyatt et al., 1996; Kelley et al., 1994; Kelley et al., 1999; Osakada et al., 2008).  Other 
transcription factors such as Crx (Corbo et al., 2010; Hsiau et al., 2007) and RORβ (Jia et 
al., 2009) have been hypothesized to regulate Nrl, although prior to this work there has 
been little evidence for direct transcriptional regulation.  The first aim of this thesis 
project, therefore, was to identify the discrete DNA binding sites and transcription 
factors that regulate Nrl expression in the mouse retina.  
 Our work and other similar, recently published research (Kautzmann et al., 2011) 
have elucidated factors contributing to Nrl regulation in rod photoreceptors, including 
Crx, RORβ, and Otx2.  However, one fundamental questions remains:  what factors 
determine whether or not a photoreceptor precursor will turn on Nrl initially?  Many 
binary cell fate decisions, similar to the rod versus cone decision, have been described in 
the literature (Arinobu et al., 2007; Niwa et al., 2005; Schaffer et al., 2010), and they 
often involve two antagonistic transcription factors that eventually promote one fate over 
the other (reviewed in Zhou and Huang, 2011; Graf and Enver, 2009).  It is possible, 
therefore, that photoreceptor precursors may co-express Nrl and a second reciprocal 
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transcription factor that promotes cone cell fate.  A cone-promoting factor has in fact 
been identified in the zebrafish:  loss of Tbx2b causes the ‘lots-of-rods’ phenotype where 
there is a one-for-one transformation of UV-cone precursors into rods (Alvarez-Delfin et 
al., 2009).  Our unpublished studies of Tbx2 deletion in the mouse retina, however, 
suggest that the ‘lots-of-rods’ phenotype is not conserved (data not shown).  Of course, it 
is possible and even likely that multiple factors converge to dictate rod versus cone cell 
fate in the mouse, such as transcription factor expression, small molecule signaling, and 
cell-cell interaction. 
 
Nrl activity in the developing and adult retina 
Once Nrl expression is established, it plays a critical role in the development and 
maintenance of the rod phenotype.  Numerous studies have implicated Nrl as a 
transcriptional activator of rod genes (Corbo et al., 2007), including the downstream 
transcription factor Nr2e3 (Oh et al., 2008; Peng and Chen, 2005), rod pigment Rho 
(Chen and Zack, 1996; Peng and Chen, 2011; Rehemtulla et al., 1996), signal 
transduction protein Pde6b (Lerner et al., 2001), and myocyte enhancer Mef2c (Hao et 
al., 2011).  A recent Nrl ChIP-seq study in the mouse retina (Hao et al., 2012) has 
identified many other genes whose promoter elements are bound by Nrl.  This dataset 
overlaps strongly with Crx binding data from a Crx ChIP-seq study (Corbo et al., 2010), 
implying that many rod genes are co-regulated by Nrl and Crx.  In addition to serving as 
an important activator of rod genes, Nrl has also been shown to directly suppress cone 
genes including the transcription factor Thrb and blue cone pigment Opn1sw (Oh et al., 
2007). 
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Other regulators of photoreceptor differentiation 
Otx2, Crx, and Nrl may be the most extensively studied regulators of photoreceptor 
differentiation, but numerous other transcription factors have also been shown to mediate 
rod and cone development, including RORβ, Nr2e3, TRβ2 and Sall3. 
 RORβ is an orphan nuclear receptor with two known isoforms expressed in the 
central nervous system (Andre et al., 1998; Schaeren-Wiemers et al., 1997); RORβ2 is 
restricted to the pineal gland and retina (Andre et al., 1998).  The Rorb null retina has a 
dearth of rods and an excess of S-cones (Jia et al., 2009).  However, these cones exhibit 
late onset of S-opsin expression and lack outer segments (Jia et al., 2009; Srinivas et al., 
2006).  RORβ functions upstream of Nrl during photoreceptor development, as Rorb null 
retinas lack Nrl expression (Jia et al., 2009).  Since this gene appears to regulate 
transcription in both rod and cone photoreceptors, however, its role in rod versus cone 
determination is unclear. 
 Another orphan nuclear receptor, Nr2e3, originally caught the attention of 
photoreceptor biologists when mutated copies of this gene were found in human patients 
with enhanced S-cone syndrome (Haider et al., 2000).  Later studies of rd7 mice lacking 
functional Nr2e3 (Akhmedov et al., 2000; Chen et al., 2006) found that this rod-specific 
transcription factor, like Nrl, can directly activate rod genes and repress cone genes 
(Corbo and Cepko, 2005; Haider et al., 2009; Peng et al., 2005).  Unlike the ‘true’ cones 
of the Nrl null retina, however, Nr2e3 null photoreceptors appear to be rod-cone hybrids 
that exhibit molecular and morphological characteristics of both cell types (Corbo and 
Cepko, 2005; Webber et al., 2008).  Moreover, a subset of cone genes appears to be  
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regulated primarily by Nrl and not Nr2e3 (Corbo and Cepko, 2005).  Thus, Nr2e3 is 
thought to function downstream of Nrl in the development and maintenance of the rod 
phenotype. 
 TRβ2 (Thrb) and Sall3 are two transcription factors important in the specification 
of cone subtype.  The mouse has two cone photopigments, medium-wavelength opsin 
(M-opsin) and short-wavelength opsin (S-opsin) (Szel et al., 1992).  These opsins are 
expressed in a spatial gradient across the retina, with a higher localization of M-opsin 
dorsally and greater S-opsin ventrally (Szel et al., 1992).  Most S-opsin-expressing cones 
also express M-opsin, although a small number of cones express S-opsin exclusively 
(Haverkamp et al., 2005; Rohlich et al., 1994).  In the Thrb null retina, M-opsin is 
completely absent, and cones throughout the retina instead express S-opsin alone (Ng et 
al., 2001).  This suggests that developing cones default to the S-cone pathway and require 
TRβ2 to turn on M-opsin (Ng et al., 2001).  In contrast, Sall3 appears to play an 
important role in the regulation of S-opsin in the mouse:  Sall3-null retinal explants have 
reduced expression of S-opsin, and Sall3 overexpression by electroporation is sufficient 
to induce ectopic S-opsin expression in wild-type retinas (de Melo et al., 2011). 
  
Thus, decades of research have produced a detailed model for the development of the 
vertebrate retina.  Yet there are many areas of ongoing investigation regarding retinal 
differentiation, including characterization of the retinal progenitor cell at the 
transcriptional level (Blackshaw et al., 2004; Hafler et al., 2012), three dimensional 
control of photoreceptor gene transcription in the nucleus (Peng and Chen, 2011), 
epigenetic mechanisms involved in retinal development (Hackler et al., 2010; Merbs et 
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al., 2012; Nasonkin et al., 2011), and the generation of differentiated retinal cells from 
embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) for the purpose of 
treating disease (Lamba et al., 2010; Osakada et al., 2008; Pearson et al., 2012).  I will 
address the last area of research in the second part of this chapter by reviewing the history 
of cellular reprogramming.  I will also argue that our knowledge of factors involved in 
retinal cell differentiation may be applied to a new therapeutic strategy for retinal disease:  
direct conversion of one retinal cell type into another. 
 
1.4 Reprogramming somatic cells: early experiments and iPSCs 
 
In the 1950s, Conrad Waddington postulated that cellular differentiation occurs on an 
epigenetic landscape composed of ridges and valleys (Waddington, 1957).  He likened 
the establishment of cell identity to a marble rolling downhill towards a final, stable state.  
For several decades, the process of differentiation was thought to be irreversible. 
 
Early experiments in cellular reprogramming 
In 1983, Blau and colleagues performed the first experiment demonstrating that cells 
could be induced to express previously silent genes (Blau et al., 1983):  fusion of human 
amniotic fibroblasts with mouse muscle cells produced a heterokaryon with stable 
expression of muscle genes including myosin light chain and creatine kinase.  Subsequent 
heterokaryon experiments in different systems corroborated cell fusion as a means to 
reprogram cellular phenotypes (Baron and Farrington, 1994; Baron and Maniatis, 1986; 
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Bergman and Ringertz, 1990), and experimental heterokaryons are still generated today 
to study the reestablishment of pluripotency (reviewed in Piccolo et al., 2011). 
 A second reprogramming breakthrough occurred in 1987, when Davis and 
colleagues demonstrated that ectopic expression of a single myoblast cDNA, MyoD, was 
sufficient to convert mouse embryonic fibroblasts into stable myoblasts (Davis et al., 
1987).  MyoD was later shown to induce muscle gene expression in fibroblasts derived 
from multiple tissue types, including nerve, fat, and liver (Weintraub et al., 1989).  These 
experiments established the power of a transcription factor to reprogram somatic cell 
identities. 
 
Induced pluripotent stem cells 
In 2006, Takahashi and Yamanaka published a landmark study describing the conversion 
of mouse fibroblasts into pluripotent stem cells by overexpression of four transcription 
factors, Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi and Yamanaka, 2006).  These cells, 
termed induced pluripotent stem cells or iPSCs, were able to give rise to many different 
tissues when grafted into nude mice.  The result was soon replicated in human fibroblasts 
via two different transcription factor cocktails (Takahashi et al., 2007; Yu et al., 2007).  
These studies launched a new field of research concerned with the generation and 
controlled re-differentiation of iPSCs for therapeutic purposes (reviewed in Boucherie et 
al., 2011; Dolmetsch and Geschwind, 2011; Robinton and Daley, 2012; Wu and 
Hochedlinger, 2011), and stoked debate among scientists and the general public about the 
continued study of human embryonic stem cells in the laboratory (Bilic and Izpisua 
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Belmonte, 2012; Power and Rasko, 2011; Puri and Nagy, 2012; Zarzeczny and Caulfield, 
2009). 
 While iPSCs are a promising source for customized cell-replacement therapies, 
there are still numerous technical hurdles to overcome.  First, fibroblast reprogramming 
to the pluripotent state is inefficient and slow.  In their 2007 human iPSC paper, 
Takahashi and colleagues reported successful reprogramming of 10 cells out of 5 x 104 
originally transduced with the transcription factor cocktail, and emergence of ESC-like 
properties required culture for 30 days (Takahashi et al., 2007).  Many groups have 
worked to improve the reprogramming efficiency by overexpressing additional factors 
such as UTF1 (Zhao et al., 2008), knocking down factors like p53 and DNA 
methyltransferase (Mikkelsen et al., 2008; Zhao et al., 2008), and treating cultures with 
small molecules such as 5-azacytidine and valproic acid (Huangfu et al., 2008; Mikkelsen 
et al., 2008) (reviewed in Feng et al., 2009).  Second, some factors used for 
reprogramming, notably c-Myc, are oncogenic (reviewed in Eilers and Eisenman, 2008), 
and iPSC tumorigenicity is a valid concern (Okita et al., 2007).  Scientists have begun to 
address this issue by searching for non-genetic methods for iPSC induction (Huangfu et 
al., 2008; Shi et al., 2008).  Third, iPSCs have been found to retain a ‘transcriptional 
memory’ of their cell of origin, due in part to incomplete DNA methylation at isolated 
loci (Kim et al., 2010; Ohi et al., 2011).  This discovery has refreshed the debate of 
whether iPSCs are truly equivalent to ESCs in terms of their differentiation potential 
(Barrero and Izpisua Belmonte, 2011). 
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1.5 Direct reprogramming of differentiated cells 
 
The multitude of issues associated with iPSCs has refocused attention on an alternative 
strategy for cell renewal:  direct reprogramming of one somatic cell type into another, 
without an intervening pluripotent state (reviewed in Chambers and Studer, 2011; Graf 
and Enver, 2009; Vierbuchen and Wernig, 2011).  Since the original MyoD experiments 
of the 1980s, numerous investigators have achieved success in transcription factor-based 
transdifferentiation of various cell types, both in vitro and in vivo. 
 
B cells to T cells via a lymphoid progenitor 
Transcriptional regulation of hematopoietic differentiation has been investigated for 
decades, and scientists have discovered numerous factors controlling cell fate decisions 
within this system (reviewed in Naito et al., 2011; Santos et al., 2011).  One example is 
Pax5, which promotes the commitment of lymphoid progenitors to the B cell pathway 
(reviewed in Medvedovic et al., 2011).  In 2007, Cobaleda and colleagues deleted Pax5 in 
mature B cells, which resulted in dedifferentiation to the uncommitted lymphoid 
progenitor state.  These progenitors were then able to re-differentiate as functional T cells 
in T-cell deficient mice (Cobaleda et al., 2007).  This experiment demonstrated that 
interconversion between closely related cell types is possible without complete reversion 
to the pluripotent state. 
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Pancreatic exocrine cells to β-cells 
In 2007-2008, Zhou and colleagues identified transcription factors important for 
pancreatic β-cell development (Zhou et al., 2007) and overexpressed them in mouse 
pancreatic exocrine cells in vivo (Zhou et al., 2008).  A combination of three factors, 
Ngn3, Pdx1, and Mafa, was shown to induce direct reprogramming of exocrine cells into 
insulin-secreting β-cells.  These induced β-cells resembled islet β-cells morphologically 
and molecularly, and were able to ameliorate hyperglycermia in diabetic mice (Zhou et 
al., 2008).  An impressive 20% of transduced cells became insulin-positive, and 
investigators detected reprogramming events after only 3 days.  This supports the 
hypothesis that transdifferentiation between related cell types is more efficient than 
reprogramming of iPSCs, possibly because the two cell types likely share many 
epigenetic modifications (Zhou et al., 2008). 
 
Fibroblasts to neurons 
A common, direct lineage is not essential for successful somatic reprogramming, as 
shown by recent experiments utilizing fibroblasts.  In 2010, Vierbuchen and colleagues 
were the first to achieve conversion of mouse fibroblasts into functional neurons 
(Vierbuchen et al., 2010).  Starting with a pool of 19 genes important in neuronal 
development and epigenetic reprogramming, investigators eventually isolated a set of just 
three factors, Ascl1, Brn2, and Myt1l, that was sufficient to reprogram cultured 
embryonic and tail fibroblasts to neuron-like cells.  These cells expressed pan-neuronal 
markers like NeuN and MAP2, formed functional synapses, and produced action 
potentials in response to membrane depolarization (Vierbuchen et al., 2010).  Other 
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groups have since generated glutamatergic and dopaminergic neurons from both mouse 
and human fibroblasts (Caiazzo et al., 2011; Pang et al., 2011; Yoo et al., 2011). 
 
Fibroblasts to cardiomyocytes 
Direct fibroblast reprogramming is possible in other systems as well.  In 2010, Ieda and 
colleagues successfully transformed cultured cardiac fibroblasts into cardiomyocytes via 
three transcription factors, Gata4, Mef2c, and Tbx5 (Ieda et al., 2010).  These factors 
were isolated from an original pool of 14 factors using a screening approach similar to 
that of Vierbuchen et al. (2010).  The induced cardiomyocytes expressed cardiac-specific 
proteins including α-actinin and atrial natriuretic factor, had similar epigenetic 
modifications as normal cardiomyocytes at particular gene loci, and exhibited 
spontaneous contraction (Ieda et al., 2010).  Two years later, the same group reported that 
cardiac fibroblasts could be directly converted into functional cardiomyocytes in vivo 
(Qian et al., 2012).  These reprogrammed cells even more closely resembled true 
cardiomyocytes than the previous in vitro-differentiated cells, possibly due to factors 
provided by the native cardiac environment.  The induced cardiomyocytes were even able 
to produce modest attenuation of cardiac dysfunction in an infarct model (Qian et al., 
2012).  Thus, this experiment and the insulin-positive β-cell experiment provide 
optimism for the treatment of human disease via direct, in vivo cellular reprogramming. 
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1.6 Reprogramming and the treatment of retinal disease 
 
Cellular regeneration is of particular relevance to the study of retinal disease.  Mutations 
in any one of more than 200 genes can result in retinal degeneration (Daiger, 1998), 
leading to significant disability in millions of people (Sohocki et al., 2001). 
 
Major obstacles in retinal gene replacement therapy 
Gene replacement therapy has shown considerable promise for the prevention and 
amelioration of inherited blindness in both model organisms and human patients 
(reviewed in Liu et al., 2011; Montana and Corbo, 2008; Smith et al., 2009).  However, 
there are several barriers to the widespread adoption of gene replacement therapy in the 
treatment of blindness.  First, patients with advanced disease have often lost the majority 
of their photoreceptors and thus may benefit only from some form of cell replacement 
therapy (reviewed in Gaillard and Sauve, 2007; Stone, 2009).  Second, the sheer diversity 
of disease-causing mutations presents a daunting challenge for researchers, who must 
design and validate delivery systems for each gene individually.  Thus, there is a strong 
motivation to develop gene-independent therapies that would be applicable to larger 
families of disease (Farrar et al., 2002; Stieger and Lorenz, 2010).  Third, dominant 
alleles account for a large percentage of retinal disease (Daiger, 1998), and particularly of 
retinitis pigmentosa (Farrar et al., 2010).  Treatment of these patients will likely require 
suppression of the mutated allele in addition to the delivery of a wild-type copy.  While 
this is theoretically possible via siRNA or other gene knockdown approaches (Farrar et 
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al., 2002; O'Reilly et al., 2007), so far this technology has not been tested in humans or 
even in larger model organisms such as canines.  
 To address the first obstacle, researchers have turned to ESCs and iPSCs as 
sources for new photoreceptors, which might then be transplanted into patient retinas 
(Lamba et al., 2010; MacLaren et al., 2006; Osakada et al., 2008; Pearson et al., 2012).  
To address the second and third obstacles, I propose a new treatment model:  direct 
conversion of rod photoreceptors into cones, to bypass complications arising from rod-
specific mutations. 
 
The treatment of retinitis pigmentosa by direct reprogramming of rods into cones 
Retinitis pigmentosa is the most common form of inherited retinopathy, with a  
worldwide prevalence of approximately 1:3000-5000 (Chizzolini et al., 2011; Haim, 
2002).  It is often caused by mutations in rod-specific genes (Daiger, 1998), which result 
in initial rod photoreceptor death and night blindness (Hartong et al., 2006).  While this is 
generally well tolerated by patients, the death of rods is often followed by secondary cone 
degeneration (Hartong et al., 2006; Punzo et al., 2012), which leads to functionally 
debilitating loss of daytime, color, and high acuity vision (Fig. 1.2).   
 The molecular mechanism driving secondary cone degeneration is currently an 
open question.  Growing evidence suggests, however, that loss of rods and collapse of the 
retinal architecture generates a metabolic environment that is toxic to cones (Komeima et 
al., 2006; Punzo et al., 2009; Punzo et al., 2012; Shen et al., 2005; Usui et al., 2009).  In 
this case, preservation of the ONL structure may be sufficient to foster cone survival.  In 
the second part of this thesis, I tested the hypothesis that primary rod cell death, due 
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to mutations in rod-specific genes, would be circumvented by forced 
reprogramming of diseased rods into cone photoreceptors.  This would prevent 
collapse of the ONL and secondary degeneration of endogenous cones, thus preserving 
cone function. 
 Photoreceptors are highly specialized cell types and so far there has been no 
evidence that they retain phenotypic plasticity following differentiation.  However, rods 
and cones share numerous molecular (Corbo et al., 2007), morphological (Carter-Dawson 
and LaVail, 1979a), and functional (Luo et al., 2008) characteristics.  Also, their 
specification during development appears to hinge on a single transcription factor, Nrl 
(Mears et al., 2001).  For these reasons, and also because of the success of transcription 
factor-based reprogramming in other systems, we hypothesized that acute knockout of 
Nrl in rod photoreceptors would elicit direct reprogramming to the cone phenotype. 
 
In conclusion, the study of retinal development has evolved with an increased emphasis 
on the molecular mechanisms underlying cellular differentiation and disease.  The aim of 
this thesis is two-fold:  first, to elucidate factors governing the expression of the rod 
photoreceptor determinant Nrl, and second, to manipulate this determinant for the 
purpose of treating retinal disease.  Ultimately, this work seeks to further our 
understanding of both the establishment and potential plasticity of the differentiated state. 
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Figure 1.1:  The photoreceptor transcriptional network.  Crx is a master regulator of 
many photoreceptor genes, including transcription factors that govern rod and cone 
differentiation.  Nrl is necessary for the development of rod photoreceptors; it activates 
rod genes including the transcription factor Nr2e3, while repressing cone genes. 
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Figure 1.2:  Typical progression of retinitis pigmentosa.  Mutations in rod-specific 
genes cause initial rod dysfunction and death, resulting in night blindness.  Rod death 
then leads to secondary cone dysfunction and death, with loss of central, color, and high 
acuity vision. 
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Transcriptional regulation of Nrl by Crx, Otx2, 
and RORβ 
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2.1 Introduction 
Nrl is a Maf-family transcription factor that is required for mouse rod photoreceptor 
development (Mears et al., 2001).  Nrl is expressed in the wild-type retina starting around 
E12 (Akimoto et al., 2006), coincident with the beginning of the rod birth period (Cepko 
et al., 1996; Young, 1985).  It subsequently activates numerous rod-specific genes 
including Rhodopsin (Kumar et al., 1996; Rehemtulla et al., 1996) and many components 
of the rod-specific phototransduction cascade (Corbo et al., 2007; Yoshida et al., 2004).  
Nrl simultaneously represses cone genes in rods, either directly (Peng and Chen, 2005) or 
by activating the downstream repressor Nr2e3 (Chen et al., 2005; Corbo and Cepko, 
2005; Oh et al., 2008; Peng et al., 2005).  In the Nrl null retina, rod gene expression fails 
to initiate and rod precursors show a derepression of cone genes which results in a 
transfating of the cells into cones in the adult retina (Daniele et al., 2005; Mears et al., 
2001).  Nrl expression is the earliest known marker of rod photoreceptor identity 
(Akimoto et al., 2006), and expression persists at high levels in the outer nuclear layer 
throughout adulthood (Hsiau et al., 2007).  Not surprisingly, mutations in human NRL 
often result in heritable retinal disease, most commonly autosomal dominant retinitis 
pigmentosa (Daiger, 1998). 
 Despite the importance of Nrl in the photoreceptor transcriptional network as well 
as in human disease, the mechanisms by which Nrl transcription is regulated are 
incompletely understood.  Akimoto and colleagues (2006) have shown that a 2.5-kb 
region upstream of Nrl is sufficient to drive GFP expression in rod photoreceptors.  
However, specific binding sites for transcriptional regulators within this promoter region 
remain unknown.  An earlier study of the Nrl promoter (Khanna et al., 2006) utilized a 
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heterologous cell culture assay to identify promoter elements responsive to the rod fate 
inducer retinoic acid (Kelley et al., 1994), but these sites have not yet been tested in vivo.  
Nrl has also been hypothesized to be a regulatory target of other retinal transcription 
factors such as Crx (Corbo et al., 2010; Hsiau et al., 2007) and RORβ (Jia et al., 2009), 
but it is unclear whether this regulation is direct or indirect.  In this study, we sought to 
identify discrete cis-regulatory motifs and the transcription factors which bind them to 
regulate activation of the Nrl promoter. 
 In order to conduct the Nrl promoter analysis in the living mouse retina, we 
utilized a retinal explant electroporation assay (Matsuda and Cepko, 2004).  This system 
has been used previously to quantify the activity of photoreceptor-specific cis-regulatory 
regions (Lee et al., 2010), and represents a much more realistic means of analyzing cis-
regulation than traditional mammalian cell culture approaches.  Using this system, we 
have found that three retinal transcription factors—Crx, Otx2, and RORβ—activate Nrl 
transcription by binding directly to a highly conserved region of the Nrl promoter. 
 
2.2 A 30-nucleotide region is critical for Nrl promoter activity 
In order to identify the cis- and trans-acting factors required for regulation of Nrl, we 
undertook a detailed analysis of its proximal promoter region.  A previous study 
demonstrated that a 3.2-kb fragment of the mouse Nrl promoter (from -2345 to +865 bp 
relative to the Nrl transcription start site) is sufficient to drive strong rod photoreceptor-
specific expression in electroporated retinas (Matsuda and Cepko, 2007).  This fragment 
contains three blocks of high phylogenetic conservation (denoted P1, P2 and P3 in Fig. 
2.1A) which correspond to regions bound by Crx in vivo as identified in a recent genome-
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wide ChIP-seq study (Corbo et al., 2010).  We created a series of Nrl promoter 
truncations to narrow down the minimal promoter region required for Nrl expression 
(Fig. 2.1A).  These promoter truncations were fused to the fluorescent reporter DsRed 
and electroporated into P0 retinal explants along with the loading control pNrl(3.2 kb)-
GFP.  The 3.2 kb and 2.9 kb constructs (both encompassing P1, P2 and P3) expressed 
strongly in explant cultures after eight days (Fig. 2.1B). Interestingly, the 2.5 kb and 1.1 
kb constructs that encompassed only P2 and P3 drove equally strong expression (Fig. 
2.1B).  Elimination of P2 in the 0.8 kb and 0.3 kb constructs, however, caused complete 
loss of pNrl-DsRed expression, suggesting that P2 harbors cis-regulatory motifs critical 
for Nrl expression. 
 To identify these motifs within the P2 block, we performed scanning mutagenesis 
over a 160-bp region (Fig. 2.1C).  Ten adjacent nucleotides were mutated at a time via 
site-directed mutagenesis in the pNrl(1.1 kb)-DsRed construct.  The promoter activity of 
the 16 resultant constructs was then quantified by explant electroporation.  Most 
mutations had relatively modest effects on promoter activity (Fig. 2.1C).  However, 
constructs 12, 13 and 14—encompassing a 30-nucleotide block immediately upstream of 
the transcription start site—failed to drive any detectable DsRed expression.  This 30-
nucleotide span was denoted the ‘critical region’ because of its indispensable role in Nrl 
promoter activity. 
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2.3 The critical region contains functional Crx and RORβ binding sites 
Examination of the 30-nucleotide critical region revealed near-consensus binding sites for 
two key photoreceptor transcription factors, Crx and RORβ, spaced seven nucleotides 
apart (Fig. 2.2A).  The Rorb gene encodes two transcript isoforms, RORβ1 and RORβ2 
(Andre et al., 1998), which encode proteins with somewhat different DNA-binding 
preferences.  Whereas RORβ1 is widely expressed, RORβ2 is preferentially expressed in 
photoreceptors and the pineal gland (Andre et al., 1998).  Interestingly, the AGGTCA 
core element of the putative RORβ site in the Nrl promoter's critical region is 
immediately preceded by a thymidine nucleotide, which favors binding by the 
photoreceptor-enriched isoform RORβ2 (Andre et al., 1998). 
 To test the functionality of these two sites within the pNrl(1.1 kb)-DsRed reporter, 
we created point mutations predicted to abolish Crx binding (‘Crx mut’) or RORβ 
binding (‘RORβ mut1’ and ‘RORβ mut2’) (Andre et al., 1998; Lee et al., 2010).  All 
three constructs resulted in a complete loss of expression in retinal explants (Fig. 2.2A).  
Next, we tested whether the critical region has intrinsic promoter and/or enhancer activity 
(Fig. 2.2B).  To test promoter activity, we cloned the critical region (‘CR’) upstream of a 
minimal basal promoter from bovine Rhodopsin which, by itself, does not drive any 
expression in photoreceptors (Hsiau et al., 2007).  This construct failed to drive DsRed in 
explants (Fig. 2.2B, top panel).  To determine whether the critical region could enhance 
the activity of an adjacent active promoter,  we cloned it upstream of a promoter fragment 
from mouse Rhodopsin (‘Rho-prox’) which can drive moderate levels of DsRed 
expression by itself (Fig. 2.2B, middle panel).  Fusion of the critical region to Rho-prox 
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markedly boosted DsRed expression (Fig. 2.2B, bottom panel).  Thus, the critical region 
lacks autonomous promoter activity but can act as a potent enhancer. 
 Lastly, we evaluated the relative contributions of the Crx and RORβ sites to the 
critical region enhancer activity (Fig. 2.2C-D).  Three new constructs were created on the 
[critical region]-[Rho-prox]-DsRed backbone which eliminated the Crx site alone, the 
RORβ site alone or both.  These constructs were electroporated into retinal explants (Fig. 
2.2C) and fluorescence levels were quantified (Fig. 2.2D).  Mutation of the RORβ site 
elicited a greater reduction in enhancer activity than the Crx site mutation, while mutation 
of both sites caused an almost complete loss of critical region enhancer activity (Fig. 
2.2D). 
 
2.4 The conserved sequence upstream of the critical region contains additional 
cis-motifs 
With one exception, scanning mutagenesis of individual 10-bp blocks upstream of the 
critical region (constructs 1 through 11) resulted in modest decrements in promoter 
activity, in some cases down to ~50% of wild-type levels (Fig. 2.1C).  This observation, 
and the fact that this region is highly conserved phylogenetically, suggested that it might 
contain multiple transcription factor binding sites that coordinately regulate promoter 
activity.  To test this idea, we engineered five additional truncations of the Nrl promoter 
across this region and electroporated them into retinal explants as DsRed fusion 
constructs (Fig. 2.3A-B).  As quantified in Fig. 2.3C, graded truncation of the Nrl 
promoter correlated with graded loss of promoter activity (Fig. 2.3C).  Thus, the 110-bp 
sequence immediately upstream of the Nrl critical region is indispensable for Nrl 
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promoter activity, despite the fact that no specific 10-bp block within the region is strictly 
required for expression. 
 
2.5 Coordinate regulation of Nrl by Crx and Otx2 
Explant electroporation experiments determined that a putative Crx binding site is 
essential for Nrl promoter activity.  In addition, a prior study showed a marked decrement 
in Nrl transcript levels in P28 Crx-/- retinas by in situ hybridization (Hsiau et al., 2007).  
In order to determine the temporal dependence of Nrl expression on Crx, we measured 
Nrl transcript levels across developmental time in wild-type and Crx-/- retinas (Fig. 2.4A).  
Reverse transcription quantitative PCR (RT-qPCR) showed that Nrl transcript levels are 
similar in wild-type and Crx-/- retinas until P7, after which the levels fall off sharply in 
Crx-/- compared to wild-type (Fig. 2.4A).  This result suggests that Crx is not required for 
the initiation of Nrl expression in vivo, but that it is necessary for maintenance of Nrl 
transcription at later timepoints.  In a second experiment, we co-electroporated pNrl(3.2 
kb)-DsRed and control pCAG-GFP into P0 wild-type and Crx-/- retinal explants.  After 
ten days in culture, pNrl(3.2 kb)-DsRed expression was moderately reduced in Crx-/- 
explants relative to wild-type (Fig. 2.4B), confirming that Crx plays only a minor role in 
activating the Nrl promoter in the early postnatal period.   
 These two results are seemingly at odds with the observation that mutation of a 
single putative Crx binding site within the critical region completely abolishes Nrl 
promoter activity in electroporated retinas in the early postnatal period (Fig. 2.2A).  In 
order to account for this discrepancy, we hypothesized that the retinal transcription factor 
Otx2 might be able to compensate for Crx at early timepoints.  Otx2 and Crx are both 
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K50 homeodomain transcription factors required for photoreceptor development (Chen et 
al., 1997; Furukawa et al., 1997; Nishida et al., 2003), and they have nearly identical 
DNA-binding preferences (Chatelain et al., 2006; Lee et al., 2010).  In addition, Otx2 is 
required for initiation of Crx expression (Nishida et al., 2003).  Otx2 and Crx are both 
expressed at high levels in differentiating photoreceptors through P3.5 (Fig. 2.4C).  By 
P10.5, however, Otx2 levels have decreased in photoreceptors while Crx levels remain 
high (Fig. 2.4C).  At the adult stage, expression of Otx2 persists in photoreceptors at only 
very low levels whereas Crx is maintained at high levels (Hsiau et al., 2007).  Thus, it is 
reasonable to surmise that both Otx2 and Crx may bind to the Nrl promoter critical region 
in the early postnatal period to activate Nrl transcription.  As photoreceptor Otx2 levels 
decline later, Crx may become the predominant activator of Nrl. 
 To test the hypothesis that both Crx and Otx2 activate the Nrl promoter in the 
early postnatal period, we performed a series of explant electroporations utilizing retinas 
from the Otx2f/f mouse which is homozygous for a conditional ('floxed') allele of Otx2 
(Fig. 2.4D).  Electroporation of pNrl(3.2 kb)-DsRed and control pCAG-GFP into Otx2f/f 
explants resulted in strong DsRed expression after ten days (Fig. 2.4D, first panel).  To 
eliminate Crx alone, we co-electroporated a Crx RNAi construct (Matsuda and Cepko, 
2004) along with the fluorescent reporters which resulted in a decrease in pNrl-DsRed 
expression (Fig. 2.4D, second panel).  Interestingly, the decrease in expression was 
greater than what was observed when the pNrl-DsRed construct was electroporated into 
Crx-/- retinas (Fig. 2.4B).  This difference might be explained by the fact that in the Crx-/- 
retina, there is ~2-fold increase in Otx2 expression (Hsiau et al., 2007).  Thus, in the 
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acute RNAi-mediated knockdown of Crx, there may be insufficient time for 
compensatory Otx2 upregulation.  
 To acutely knockout Otx2 alone, we co-electroporated a plasmid encoding Cre 
recombinase along with the fluorescent reporters and again observed decreased pNrl-
DsRed expression (Fig. 2.4D, third panel).  Since initiation of Crx expression depends on 
Otx2 (Nishida et al., 2003), one might expect that knockout of Otx2 would result in loss 
of both Otx2 and Crx.  However, some residual expression of the DsRed reporter was still 
apparent in photoreceptors when Otx2 was knocked out (Fig. 2.4D, third panel).  We 
therefore hypothesized that there may be some perdurance of Crx transcripts in the Otx2 
knockout.  Thus, to decrease Crx and Otx2 transcript levels simultaneously, we co-
electroporated both Crx RNAi and Cre recombinase.  This dual knockdown approach 
reduced pNrl-DsRed expression to nearly undetectable levels (Fig 2.4D, fourth panel), 
supporting our hypothesis that Crx and Otx2 are both necessary for activation of the Nrl 
promoter during rod photoreceptor development.  In addition, these findings are 
consistent with the idea that both Crx and Otx2 mediate Nrl activation by binding to the 
'Crx' site present in the critical region. 
 
2.6 Otx2, Crx, and RORβ bind directly to the Nrl promoter 
Next, we wished to determine whether Otx2, Crx and RORβ bind the bioinformatically 
identified sites within the critical region of the Nrl promoter.  First, we performed an 
electrophoretic mobility shift assay (EMSA) with biotinylated probes containing the 
sequence of the critical region (Fig. 2.5).  Recombinant proteins consisting of the DNA 
binding domains of Otx2, Crx and RORβ were purified, mixed with the probes, and run 
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on a non-denaturing gel.  Otx2 and Crx protein were both able to shift the biotinylated 
probe containing the wild-type critical region sequence (Fig. 2.5, top two panels, third 
row), and the shift was eliminated by non-biotinylated competitor probe (fourth row).  
Mutation of the Crx site alone completely abolished the shift (fifth row); mutation of the 
RORβ site alone did not affect the shift (sixth row); and mutation of both the Crx and 
RORβ sites again abolished the shift (seventh row).  Likewise, RORβ was able to shift 
the wild-type probe (bottom panel, third row) and the probe containing a Crx mutation 
(fifth row) but was unable to shift the probes containing mutations of the RORβ site 
(sixth row) or RORβ and Crx sites (seventh row).  This result indicates that Otx2, Crx 
and RORβ bind strongly and specifically to their cognate sites in the Nrl critical region in 
vitro. 
 To test whether Otx2, Crx and RORβ bind to the Nrl critical region in vivo, we 
performed a chromatin immunoprecipitation experiment utilizing mouse retinal tissue 
isolated at three postnatal timepoints.  Antibodies to Otx2 and Crx produced enrichment 
of the Nrl critical region at all three timepoints, with peak Otx2 binding at P3 and peak 
Crx binding at P7 (Fig. 2.6).  As a control, the promoter of the microglial gene Tyrobp—
which is not predicted to bind either Crx or Otx2—was not enriched.  Two different 
polyclonal antibodies against RORβ did not show enrichment of the critical region (data 
not shown).  However, these antibodies also failed to show enrichment of the blue cone 
opsin promoter region which has previously been shown to be a direct target of RORβ 
(Srinivas et al., 2006).  Thus, the absence of enrichment at the Nrl promoter in this case is 
likely attributable to the inability of these antibodies to immunoprecipitate their target. 
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2.7 Discussion 
In this study, we have shown that Otx2, Crx and RORβ directly regulate Nrl expression 
in developing mouse rod photoreceptors.  Binding sites for these factors reside in a highly 
conserved region immediately upstream of the Nrl transcription start site, and directed 
point mutations in these sites are sufficient to completely abolish pNrl-DsRed expression 
in mouse retinal explants.  EMSA experiments confirm direct binding of Otx2, Crx and 
RORβ at this region of the Nrl promoter.  Direct binding of Otx2 and Crx was further 
validated in ChIP experiments with mouse retinal lysates.  While the present paper was 
under preparation, a report appeared which corroborates our findings with respect to the 
regulation of the Nrl promoter by RORβ (Kautzmann et al., 2011). 
 An interesting conclusion from our experiments was the functional redundancy of 
Crx and Otx2 in the activation of Nrl transcription during the late embryonic and early 
postnatal periods.  Both Otx2 and Crx are required for photoreceptor cell fate 
determination (Chen et al., 1997; Furukawa et al., 1999; Nishida et al., 2003), but since 
Otx2 is required for initiation of Crx transcription (Nishida et al., 2003), it is difficult to 
distinguish the roles of these two transcription factors in the regulation of specific genes.  
A study utilizing the Otx2+/CKO; Crx-/- double knockout suggested that Otx2 itself is an 
active regulator of certain photoreceptor genes in the early postnatal period, such as Rho 
and Pde6b (Koike et al., 2007).  In the present study, we demonstrated by ChIP that Otx2 
and Crx are both bound at the Nrl promoter at P3, P7 and P21.  Moreover, Otx2 
activation of Nrl can partially compensate for the loss of Crx in the first postnatal week, 
whereas loss of both Otx2 and Crx results in a dramatic loss of Nrl promoter activation.  
Our findings suggest the following model for the initiation and maintenance of Nrl 
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transcription (Fig. 2.7).  During the initiation phase, Otx2 and RORβ are the main 
activators of the Nrl promoter.  In the later maintenance phase, however, Crx supplants 
Otx2 as the main activator of Nrl transcription. 
 While our analysis has identified two critical cis-regulatory motifs in the Nrl 
promoter, there are undoubtedly a number of other important regulatory sites that remain 
unknown.  For example, the 110-base pair region upstream of the critical region likely 
contains binding sites for multiple transcription factors that may act synergistically to 
activate Nrl expression.  We found that disruption of individual sites via scanning 
mutagenesis is not sufficient to abolish Nrl promoter activity, whereas elimination of the 
entire 110-bp region causes total loss of activity.  A couple low-affinity Crx sites are 
present in this region and may play a role in activation (data not shown).  It is possible 
that binding sites for other factors are also present. 
 Retinoic acid has long been known to foster rod photoreceptor differentiation 
(Hyatt et al., 1996; Kelley et al., 1994), thus retinoic acid receptors represent attractive 
candidate regulators of Nrl expression.  Several years ago, Khanna and colleagues 
identified three elements within the Nrl promoter region that appear to be sensitive to 
retinoic acid in a heterologous tissue culture assay system (Khanna et al., 2006).  We 
sought to test the importance of these putative retinoic acid response elements (RAREs) 
in living mouse retinas by mutating each RARE individually in the context of the 
pNrl(1.1 kb)-DsRed reporter.  Mutation of the individual RAREs resulted in only modest 
changes in DsRed expression relative to the non-mutated control (Figure 2.8).  Therefore, 
while these sites might contribute to the modulation of Nrl expression in vivo, they are 
not individually required for activation of the Nrl promoter. 
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 A recent Crx ChIP-seq study found that many photoreceptor genes are surrounded 
by a spatially distributed network of Crx-bound regions which are hypothesized to act in 
a combinatorial fashion to regulate expression of their associated gene (Corbo et al., 
2010).  The Nrl gene also appears to follow this pattern since a total of four highly 
conserved noncoding regions which correspond to Crx ChIP-seq peaks were identified 
around the locus:  P1, P2, P3 and an element within the 3rd intron (Fig. 2.1A).  The initial 
promoter truncation analysis demonstrates that the P1 element is not critical for Nrl 
promoter activation, but P1 may be involved in fine-tuning of Nrl expression levels in 
rods.  In addition, the P1 element may also contribute to maintenance of normal levels of 
Nrl expression at later developmental timepoints and in the adult. 
 The roles of the P3 region and the intronic element also remain to be explored.  
Preliminary bioinformatic analyses identified a potential Crx site in the P3 region, but 
point mutation of this site in the context of the full-length pNrl(3.2 kb)-DsRed resulted in 
only minimal changes in expression (data not shown).  It is possible that this region and 
the intronic element play a role in modulating Nrl expression outside the time window 
assayed in the present study.  
 The close proximity of the Otx2/Crx and RORβ binding sites in the Nrl promoter 
critical region is note-worthy.  We previously showed that clusters and pairs of 
transcription factor binding sites, often within 50 bp of one another, are present in many 
photoreceptor cis-regulatory regions (Corbo et al., 2010; Hsiau et al., 2007).  In fact, as 
few as three closely clustered Crx sites in the context of a synthetic cis-regulatory 
element are sufficient to drive photoreceptor-specific expression in electroporated retinas 
(Corbo et al., 2010).  Many endogenous photoreceptor cis-regulatory regions, however, 
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appear to be comprised of clusters of both Crx sites and other sites for factors such as Nrl, 
Nr2e3 and bHLH factors such as NeuroD1 (Corbo et al., 2010; Liu et al., 2008; Peng and 
Chen, 2005).  Thus, the paired Otx2/Crx-RORβ motif identified in the present study 
obeys the usual logic of photoreceptor cis-regulatory grammar.   
 In conclusion, we have identified three transcription factors—Otx2, Crx and 
RORβ—that control Nrl expression by direct binding to the Nrl promoter.  Although all 
three of these factors are present in both rods and cones and are required for gene 
expression in both cell types (Chen et al., 1997; Furukawa et al., 1997; Hsiau et al., 2007; 
Jia et al., 2009; Koike et al., 2007; Nishida et al., 2003; Srinivas et al., 2006), antibody 
and misexpression studies indicate that Nrl is likely restricted to rods (Oh et al., 2007; 
Swain et al., 2001).  How then is the rod-specific pattern of Nrl expression established?  
One possibility is that a yet-undiscovered rod-specific transcription factor functions 
upstream of Nrl and coordinates with Otx2, Crx and/or RORβ to activate Nrl 
transcription exclusively in rods.  Alternatively, it is possible that there exists a cone-
specific transcription factor X which acts as a repressor of Nrl and thereby restricts its 
expression to rods.  If Nrl were to reciprocally repress factor X's expression in rods, then 
the two factors could act together as a poised binary switch between rod and cone cell 
fate similar to what has been observed in a number of systems (Graf and Enver, 2009).  
Whereas knockout of Nrl results in a transfating of rods into UV-sensitive cones (Mears 
et al., 2001), knockout of factor X would be predicted to result in the converse 
phenotype.  A recent study in zebrafish has identified such a factor: loss of Tbx2b results 
in a 'lots of rods' phenotype in which UV cones are converted into rods (Alvarez-Delfin et 
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al., 2009).  It will be extremely interesting to determine whether an analogous factor 
exists in mammalian retinas. 
 
2.8 Materials and methods 
 
Mouse husbandry 
Adult cd1, C57BL/6, Crx-/- (Furukawa et al., 1999) and Otx2f/f (Tian et al., 2002) mice 
were maintained on a 12-hour light-dark schedule at 22oC with free access to food and 
water.  The Otx2f/f mutant (Acc. No. CDB0013K) was obtained as described (Tian et al., 
2002).  The health of the animals was regularly monitored.  All studies were conducted in 
accordance with the Guide for the Care and Use of Laboratory Animals and the Animal 
Welfare Act and were approved by the Washington University in St. Louis Institutional 
Animal Care and Use Committee (approval no. 20110089). 
 
DNA constructs 
The pNrl(3.2 kb)-DsRed and pCAG-GFP vectors have been previously described 
(Matsuda and Cepko, 2004, 2007).  pNrl(3.2 kb)-GFP was created by replacing the 
DsRed coding sequence in pNrl(3.2 kb)-DsRed with GFP, using the EcoRI and NotI 
restriction sites. 
 To create the Nrl promoter truncation constructs in Fig. 2.1, PCR was used to 
amplify the following regions of the mouse Nrl promoter relative to the transcription start 
site (RefSeq NM_001136074):  pNrl(2.9 kb), -2063 to +865; pNrl(2.5 kb), -1695 to 
+865; pNrl(1.1 kb), -202 to +865; pNrl(0.8 kb), +35 to +865; and pNrl(0.3 kb), +549 to 
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+865.  The promoter fragments were subcloned upstream of DsRed in the no-basal vector 
(Hsiau et al., 2007) using the XbaI and SmaI restriction sites. 
 Scanning mutagenesis constructs were created via site-directed mutagenesis of 
pNrl(1.1 kb)-DsRed.  The QuikChange II XL Site-Directed Mutagenesis kit (Agilent, 
Santa Clara, CA) was used with the primers listed in Table 2.1 (both sense and antisense 
primers were added to the mutagenesis PCR reaction although only sense primers are 
listed).  In general, G ↔ T and C ↔ A substitutions were made unless mutagenesis 
generated a Crx binding site (constructs #8 and #12), in which case the de novo site was 
disrupted by an alternative substitution.  Site-directed mutagenesis was also used to 
create one- or two-nucleotide mutations in the Crx and RORβ binding sites within the 
pNrl(1.1 kb)-DsRed vector, and to mutate the retinoic acid response elements as shown in 
Figure 2.8. 
 To create the CR-DsRed construct, the following oligos containing the Nrl critical 
region were kinased and annealed (restriction site-compatible ends underlined):  5’- 
ctagagttaggcgattaggctgaaaatgtaggtcacacccggtac-3’ and 5’-cgggtgtgacctacattttcagcctaat-
cgcctaact-3’, and the resultant product was subcloned upstream of DsRed in the Rho-
basal vector (Hsiau et al., 2007) with the XbaI and KpnI restriction sites.  To create [Rho-
prox]-DsRed, a 205-nucleotide region of the mouse Rho promoter was obtained by PCR 
from mouse genomic DNA using the following primers:  5’-gtactctagaatgtcaccttggcccctc-
3’ and 5’-gtacggtaccgacagagaccaaggctgct-3’.  This product was digested with XbaI and 
KpnI and subcloned upstream of DsRed in the no-basal vector.  [CR]-[Rho-prox]-DsRed 
and mutation-containing variants (Fig. 2.2C) were created by subcloning CR-containing 
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oligonucleotides into the [Rho-prox]-DsRed vector with the restriction sites SalI and 
XbaI. 
 To create the Nrl promoter truncation constructs in Fig. 2.3, PCR was used to 
amplify the following regions of the mouse Nrl promoter relative to the transcription start 
site:  pNrl(0.99 kb), -122 to +865; pNrl(0.97 kb), -102 to +865; pNrl(0.95 kb), -82 to 
+865; and pNrl(0.92 kb), -57 to +865.  The promoter fragments were subcloned upstream 
of DsRed in the no-basal vector (Hsiau et al., 2007) using the XbaI and SmaI restriction 
sites. 
 Two non-fluorescent DNA constructs were electroporated in this study.  The Crx 
RNAi construct has been previously described in Matsuda and Cepko (2004).  pNrl(1.1 
kb)-Cre was created by subcloning the Cre coding sequence from pCAG-Cre (Matsuda 
and Cepko, 2007) in place of DsRed in the pNrl(1.1 kb)-DsRed vector, using the 
restriction sites EcoRI and NotI. 
 
Electroporation and culture of explanted retinas 
Electroporation and explant culture of mouse retinas were performed as previously 
described (Hsiau et al., 2007).  Briefly, eyes were removed from decapitated P0 mouse 
pups and the retinas were dissected leaving the lens in place.  The retinas were then 
electroporated in a DNA solution consisting of the experimental DsRed reporter construct 
and a control GFP reporter construct, each at a final concentration of 0.5 μg/μl.  
Following the explant culture period, retinas were fixed, whole-mounted for quantitative 
imaging, and embedded for cryosectioning as previously described (Lee et al., 2010).  
Wild-type cd1 mice were used unless otherwise stated. 
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Quantitation of promoter activity in whole-mount retinas 
DsRed fluorescence levels were measured and normalized to control GFP values as 
described previously (Lee et al., 2010).  Briefly, 8-9 whole-mounted electroporated 
retinas for each reporter construct were imaged at 400X magnification under 
epifluorescent illumination.  Images were captured in both the red and green channels 
using a monochromatic camera (ORCA-ER; Hamamatsu, Japan).  Circles of interest were 
defined and mean pixel values were recorded for five regions overlying the 
electroporated retina and three control regions outside the retina (for background 
subtraction) in both the red and green channels using ImageJ software (NIH, Bethesda, 
MD).  For normalization, the background-subtracted mean pixel value of the 
experimental red channel was divided by the background-subtracted mean pixel value of 
the control green channel.  Standard deviation was calculated based on all normalized 
fluorescence measurements (five measurements per retina, 8-9 retinas per construct). 
 
Reverse transcription quantitative PCR for the Nrl transcript 
Retinal tissue was isolated from wild-type (C57BL/6) and Crx-/- mice (on a C57BL/6 
background).  Three biological replicates (3-4 retinas each) were collected for each time 
point.  Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA) and quantified 
using a Nanodrop device (Thermo Fisher Scientific, Waltham, MA).  cDNA was 
synthesized using the Superscript III First-Strand Synthesis System for RT-PCR 
(Invitrogen, Carlsbad, CA) with 1 μg total RNA and oligo(dT)20 primers.  Reverse 
transcription quantitative PCR (RT-qPCR) was performed using SYBR-Green (Applied 
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Biosystems, Carlsbad, CA) and the following primers (Cicero et al., 2009):  Nrl 
transcript, 5’-aacttctgagcatcgtggca-3’ and 5’-tgaagagtcgtgacctgcaaa-3’; Gapdh transcript, 
5’-ctccactcacggcaaattca-3’ and 5’-cgctcctggaagatggtgat-3’.  Three technical replicate 
PCRs were performed for each biological replicate.  For each biological replicate, Nrl 
transcript levels were normalized to control Gapdh levels (ΔCt).  ΔCt values from the 
three biological replicates were then averaged and fold-change relative to the wild-type 
P7 Nrl expression level was calculated, along with the standard deviation across the 
biological replicates. 
 
Electrophoretic mobility shift assay (EMSA) 
The DNA binding domains of Otx2 and Rorb were amplified from mouse retinal cDNA 
using the following PCR primers:  Otx2, 5’-ttcgggaattccagcgaagggagaggacga-3’ and 5’- 
tcaggcggccgcctgctgttggcggcacttag-3’; Rorb, 5’-ttcgggaattcatgtgtgagaaccagcc-3’ and 5’-
tcaggcggccgcagcctttgctgatgcttctg-3’.  The products were digested with EcoRI and NotI 
and subcloned into the pGEX-5X-1 vector (Amersham/GE Healthcare, Piscataway, NJ) 
to generate an N-terminal GST fusion.  A third GST fusion vector containing the DNA 
binding domain of Crx has been previously described (Lee et al., 2010).  The vectors 
were transformed into the Escherichia coli strain BL21 and recombinant protein was 
generated, purified and concentrated as previously described (Lee et al., 2010). 
 Sense and antisense oligonucleotides were biotinylated with the Biotin 3’ End 
DNA Labeling Kit (Pierce Biotechnology, Rockford, IL) per the manufacturer’s 
instruction and annealed.  For Crx and Otx2, DNA binding reactions were carried out at 
25oC for 1 hour in the following 20-μl reaction mixture:  1 μl recombinant protein, 1 
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fmol/μl biotinylated probe, 60 mM KCl, 25 mM HEPES (pH 7.6), 1 mM DTT, 1 mM 
EDTA, 5% glycerol.  For RORβ, binding reactions were carried out at 25oC for 1 hour in 
the following 20-μl reaction mixture:  1X binding buffer (Pierce Biotechnology, 
Rockford, IL), 2.5% glycerol, 5 mM MgCl2.  Unlabeled, annealed competitor oligos were 
added to control reactions at a final concentration of 0.2 pmol/μl (200-fold molar excess 
relative to labeled probe).  The binding reactions were run on a 10% TBE native 
polyacrylamide gel (Invitrogen, Carlsbad, CA) at 100 V for 30 minutes.  Transfer to a 
nylon membrane, cross-linking of DNA to the membrane, blocking, incubation with 
streptavidin-horseradish peroxidase conjugate, washing and chemiluminescent 
development were performed as directed by the LightShift Chemiluminescent EMSA Kit 
(Pierce Biotechnology, Rockford, IL). 
 
Chromatin immunoprecipitation (ChIP) 
ChIP assays were performed as previously described (Corbo et al., 2010) with minor 
modifications.  Briefly, 6-8 retinas were isolated from cd1 mice at each timepoint for 
each biological replicate (two biological replicates per timepoint, per antibody).  Pooled 
retinas were cross-linked with 1% formaldehyde for 15 minutes at room temperature; the 
reaction was stopped by addition of glycine to a final concentration of 0.125 M.  
Crosslinked retinas were mechanically dissociated with a mortar and pestle and lysed in 
0.5% NP-40.  The nuclear pellet was lysed with 1% SDS and 0.5% EmpigenBB and 
homogenized by sonication, 35-50 x 10 sec. at 25% amplitude (VibraCell; Sonics, 
Newtown, CT), to a chromatin fragment size range of 200-500 bp.  Immunoprecipitation 
of sheared chromatin was performed overnight at 4oC with 2.5 μg anti-Crx antibody 
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(Santa Cruz, sc-30150X) or 2.5 μg anti-OTX2 antibody (Millipore, AB9566).  Control 
precipitations were also carried out with 2.5 μg rabbit IgG (Santa Cruz, sc-2027) for each 
biological replicate.  Chromatin-antibody complexes were incubated with protein G 
Dynabeads (Invitrogen, Carlsbad, CA) for 2 hours at 4oC.  After washing and elution 
steps, crosslinks were reversed at 65oC overnight.  The immunoprecipitated DNA was 
purified using QIAquick purification columns (Qiagen, Valencia, CA). 
 Quantitative real-time PCR (qPCR) was performed on immunoprecipitated, 
purified DNA using SYBR Green (Applied Biosystems, Carlsbad, CA) with the 
following primers:  Nrl critical region, 5’-cctactagggggtgacagctc-3’ and 5’-
tctcctctctcgctcattcc-3’; Tyrobp control, 5’-tctttctgcggccatgtcta-3’ and 5’-
tgtgacgtccaaccaagtgaa-3’.  Three technical replicate PCRs were performed for each of the 
two biological replicates.  The fold enrichment of each target was calculated as 2 to the 
power of the cycle threshold (Ct) difference between IgG- and Crx-ChIP or IgG- and 
Otx2-ChIP. 
 
RNA in situ hybridization (ISH) 
ISH on retinal tissue sections was performed as previously described (Chen and Cepko, 
2000).  Briefly, either whole eyes or retinas were isolated from C57BL/6 mice at various 
timepoints.  The tissue was fixed in 4% paraformaldehyde at 4oC overnight, then 
equilibrated in 30% sucrose/PBS and embedded in OCT (Tissue Tek).  The embedded 
tissue was cryosectioned, mounted on glass slides, and hybridized with RNA riboprobes 
synthesized from PCR products derived from templates described in previous studies 
(Corbo et al., 2007; Hsiau et al., 2007). 
 Figure 2.1:  Identification of a short, conserved region critical for Nrl promoter 
activity.  (A) The fluorescent reporter DsRed was fused downstream of six different Nrl 
promoter truncations, ranging from 3.2 kb to 0.3 kb, based on blocks of phylogenetic 
conservation (P1, P2 and P3; UCSC Genome Browser Phastcons track shown) (Rhead et 
al., 2010) and previously published Crx ChIP-seq data (each black tick mark represents 
one sequence read) (Corbo et al., 2010).  (B) pNrl-DsRed truncation constructs were 
electroporated along with the pNrl(3.2 kb)-GFP loading control into retinas dissected 
from P0 mice.  After eight days in explant culture the retinas were fixed and imaged in 
flatmount.  While the 3.2 kb, 2.9 kb, 2.5 kb and 1.1 kb promoter truncations all drove 
similarly strong levels of DsRed expression, the 0.8 kb and 0.3 kb truncations failed to 
drive DsRed expression.  DsRed expression was restricted to the outer nuclear layer for 
all constructs tested, as demonstrated in the cross-section of a retinal explant 
electroporated with pNrl(3.2 kb)-DsRed and ubiquitously expressing pCAG-GFP (bottom 
panel).  (C) Scanning mutagenesis was performed on a 160-bp region within the 
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phylogenetically conserved block P2:  using the pNrl(1.1 kb)-dsRed construct as the 
vector backbone, 10 adjacent nucleotides of the P2 block were mutated at a time via site-
directed mutagenesis (G ↔ T, A ↔ C).  The 16 constructs were co-electroporated with 
pNrl(3.2 kb)-GFP into P0 retinas, grown in explant culture for eight days, and imaged in 
flatmount.  pNrl(1.1 kb, mutated)-DsRed expression, relative to pNrl(3.2 kb)-GFP 
expression, was quantified and normalized to wild-type pNrl(1.1 kb)-dsRed expression 
(‘Ctrl’).  Constructs 12, 13 and 14—encompassing 30 nucleotides total of the Nrl 
promoter—failed to drive DsRed expression.  Error bars, s.d. 
  
Figure 2.2:  Mutation of putative Crx and RORβ binding sites abolishes the activity 
of the Nrl promoter critical region.  (A) The critical region contains bioinformatically 
predicted binding sites for both Crx and RORβ.  pNrl(1.1 kb)-DsRed constructs were 
created that contain point mutations predicted to abolish Crx binding (‘CRX mut’) or 
RORβ binding (‘RORβ mut1’ and ‘RORβ mut2’).  All three mutant constructs failed to 
express in retinal explants.  (B) The critical region was isolated and fused to a basal 
promoter (123 nucleotides from the bovine Rhodopsin promoter) and DsRed but failed to 
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drive DsRed expression (top panel).  The critical region was also fused to the short 
promoter Rho-prox (205 nucleotides from the mouse Rhodopsin promoter).  While Rho-
prox can autonomously drive moderate DsRed expression (middle panel), fusion of the 
critical region with Rho-prox greatly boosts DsRed expression (bottom panel).  (C) Point 
mutations predicted to abolish binding of Crx; RORβ; or Crx and RORβ caused graded 
loss of promoter activity of the [critical region]-[Rho-prox]-DsRed construct.  (D) 
Quantification of DsRed fluorescence of the constructs shown in part (C), normalized to 
[Rho-prox]-DsRed (‘No CR’).  Error bars, s.d. 
 Figure 2.3:  Graded truncation of the Nrl promoter upstream of the critical region 
correlates with graded loss of promoter activity.  (A) Four additional Nrl promoter 
truncations—0.99 kb, 0.97 kb, 0.95 kb and 0.92 kb—were fused to DsRed and 
electroporated into retinal explants.  Note that the 1.07 kb promoter was referred to as 
‘1.1 kb’ In Figures 2.1 and 2.2.  (B) Progressive truncation of the promoter region 
immediately upstream of the critical region correlated with graded loss of promoter 
activity.  (C) Quantification of DsRed fluorescence of the constructs shown in parts (A) 
and (B), normalized to pNrl(1.07 kb)-DsRed.  Error bars, s.d. 
 50
  
Figure 2.4:  Crx and Otx2 coordinately regulate Nrl expression in the developing 
mouse retina.  (A) Reverse transcription quantitative PCR (RT-qPCR) analysis of Nrl 
transcript levels in C57BL/6 wild-type mice (blue line) and Crx null mice (orange line).  
Error bars represent standard deviation across three biological replicates.  (B) Wild-type 
and Crx null retinas were co-electroporated with pNrl(3.2 kb)-DsRed and the pCAG-GFP 
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loading control and cultured for ten days. DsRed expression was modestly reduced in 
Crx-/- retinas compared to wild-type. (C) in situ hybridizations for the Otx2, Crx and Nrl 
transcripts in wild-type retinas at various developmental timepoints.  The E14.5, P3.5 and 
P10.5 Crx images have been previously published (Hsiau et al., 2007) and are reproduced 
here for the sake of comparison.  Note that Crx and Otx2 possess nearly identical 
expression patterns in the retina from E12.5 through P3.5, with the exception that Otx2 is 
also expressed in the retinal pigment epithelium.  However, after P3.5, Otx2 levels 
diminish in the outer nuclear layer while high Crx levels are sustained.  The orange arrow 
at P10.5 denotes persistent, high-level Otx2 expression in bipolar cells of the inner retina. 
(D) Retinas from homozygous Otx2 floxed mice (Otx2 f/f) were co-electroporated with 
pNrl(3.2 kb)-DsRed and the pCAG-GFP and cultured for ten days.  Retinas that were 
additionally electroporated with Crx RNAi (2nd panel from left) or a Cre recombinase-
encoding plasmid (3rd panel from left) showed a reduction in pNrl(3.2 kb)-DsRed 
expression.  Retinas that received both Crx RNAi and Cre recombinase (4th panel) 
showed nearly undetectable levels of pNrl(3.2 kb)-DsRed. Note that the fluorescence 
enclosed by the white dotted lines indicates lens autofluorescence.  Residual DsRed 
expression in photoreceptors is indicated by white arrows. 
 Figure 2.5:  Electrophoretic mobility shift assay (EMSA) shows that Otx2, Crx and 
RORβ are capable of binding to the critical region in vitro.  Recombinant GST fusion 
proteins containing the DNA-binding domains of Otx2 (top panel), Crx (middle panel) 
and RORβ (bottom panel) were mixed with 35 bp biotinylated probes containing the Nrl 
promoter critical region (indicated at the bottom).  All three proteins caused a shift of the 
probe containing the wild-type sequence (Probe A), and this shift was eliminated by the 
 53
 54
addition of unlabeled competitor probe (200-fold molar excess).  A probe containing 
mutations in the Crx site (Probe B) was shifted by RORβ protein but not by Otx2 or Crx 
protein.  A probe containing mutations in the RORβ site (Probe C) was shifted by Otx2 
and Crx protein but not by RORβ protein.  A probe containing mutations in both the Crx 
and RORβ sites was not shifted by any of the three proteins. 
 Figure 2.6:  Chromatin immunoprecipitation (ChIP) demonstrates binding of Otx2 
and Crx to the critical region in vivo.  ChIP was performed on retinal tissue isolated at 
P3, P7 and P21 utilizing antibodies to Otx2 (top panel) and Crx (bottom panel).  
Quantitative real-time PCR was performed to measure enrichment at the Nrl critical 
region (‘Nrl CR’) and a negative control region not predicted to bind Otx2 or Crx 
(‘Tyrobp’).  Error bars represent standard deviation between two biological replicates. 
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 Figure 2.7:  Model for coordinate regulation of Nrl by transcription factors Otx2, 
Crx and RORβ.  Otx2, Crx and RORβ are hypothesized to contribute to Nrl expression 
in the early ‘initiation’ phase, with Otx2 and RORβ playing a particularly important role 
(as indicated by bold arrows).  During the later ‘maintenance’ phase of Nrl expression, 
Crx becomes a more important activator of Nrl as Otx2 levels decline in photoreceptors.  
Prior studies have suggested that Crx transcriptionally autoregulates. 
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 Figure 2.8:  Mutation of previously identified retinoic acid response elements 
(RAREs) in the Nrl promoter results in minor changes in pNrl(1.1 kb)-DsRed 
expression.  (A) Three separate RAREs (Khanna et al., 2006) were mutated by site-
directed mutagenesis in the pNrl(1.1 kb)-DsRed backbone.  Note that only the 5’ half of 
RARE #1 was mutated, in order to avoid disruption of the endogenous splice donor site 
within the first intron.  (B) The constructs were co-electroporated with pNrl(3.2 kb)-GFP 
into retinal explants, cultured for eight days, and imaged in flat-mount.  Mutation of 
RARE #1 resulted in a slight increase in DsRed expression, while mutation of RARE #2 
and RARE #3 caused slight decrements in DsRed expression.  (C) Quantification of 
dsRed fluorescence of the constructs shown in parts (A) and (B), normalized to wild-type 
pNrl(1.1 kb)-DsRed.  Error bars, s.d. 
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Construct no. Sequence of site-directed mutagenesis sense primer (mutated nucleotides underlined), 5’ to 3’ 
1 TTAACTTCTGGAGTTTCGGGGCGACACGCACCTATTTAAACAGC 
2 GAGTTTCTTTTATCACATACAAGCGGGAAACAGCTTCAGGCAGG 
3 TATCACAGCACCTATTTCCCACTAGGAAGGCAGGTTTAAACATC 
4 CCTATTTAAACAGCTTCCTTACTTGGGAAACATCTCCTTGGCTA 
5 CAGCTTCAGGCAGGTTTCCCACGAGAATTGGCTAAGTCCTACTA 
6 CAGGTTTAAACATCTCCGGTTAGCCTGCCTACTATCCCTGCTTC 
7 CATCTCCTTGGCTAAGTAAGCAGCGAACTGCTTCGGCCCCTACT 
8 GCTAAGTCCTACTATCCAGTAGGGCCGCCCTACTAGGGGGTGAC 
9 ACTATCCCTGCTTCGGCAAAGCAGCTTGGGTGACAGCTCTAAGA 
10 CTTCGGCCCCTACTAGGTTTGTCACTATCTAAGAGGCGTTAGGC 
11 TACTAGGGGGTGACAGCGAGCCTCTTAGTTAGGCGATTAGGCTG 
12 TGACAGCTCTAAGAGGCTGGTCCGTCGTAGGCTGAAAATGTAGG 
13 AAGAGGCGTTAGGCGATGCTTAGTCCCATGTAGGTCACACCCCA 
14 AGGCGATTAGGCTGAAACGTGCTTGACCACCCCAGCCGTCTGGG 
15 GCTGAAAATGTAGGTCAACAAAACTAAGTCTGGGAATGAGCGAG 
16 TAGGTCACACCCCAGCCTGAGTTTCCGGAGCGAGAGAGGAGAAG 
 
Table 2.1:  Site-directed mutagenesis primers.  
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CHAPTER 3 
 
 
Partial reprogramming of adult mouse rods into 
cones rescues retinal degeneration 
 60
3.1 Introduction 
Heritable retinal degeneration is a common cause of visual impairment and blindness, 
affecting millions of people worldwide (Sohocki et al., 2001).  Many research groups 
have focused on targeted gene therapy as a treatment for this disease (Liu et al., 2011), 
with success in both animal models and human patients (Ali et al., 2000; Beltran et al., 
2012; Cideciyan et al., 2009).  However, retinal disease can be caused by mutations in 
any one of more than 200 genes (Daiger, 1998), and the pathogenic mechanisms of 
various mutations vary greatly (Montana and Corbo, 2008).  Thus, there is a strong 
motivation to develop gene-independent therapies that would be more widely applicable 
(Farrar et al., 2002; Montana and Corbo, 2008).   
 Retinitis pigmentosa is a one subtype of retinal degeneration that might be 
particularly amenable to a gene-independent approach.  Here, mutations in rod-enriched 
genes initiate a progressive sequence of rod cell death followed by cone loss (Hartong et 
al., 2006).  Cone dysfunction is particularly debilitating for patients, yet it appears to be 
entirely secondary to rod death:  studies in animal models suggest that collapse of the 
ONL during rod degeneration may generate an oxidative, nutrient-deficient environment 
that is toxic to cones (Komeima et al., 2006; Punzo et al., 2009; Punzo et al., 2012; Shen 
et al., 2005; Usui et al., 2009).  In this case, preservation of rod cell bodies may be 
sufficient to forestall cone death. 
 In this study, we hypothesized that converting adult rods into cones could make 
the cells resistant to the effects of mutations in rod-specific genes, thereby preventing 
ONL collapse and secondary cone loss (Fig. 3.1A).  Direct, in vivo conversion of one 
differentiated cell type into another has been successful in numerous contexts, as 
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investigators have converted pancreatic exocrine cells into β-cells (Zhou et al., 2008), 
auditory endothelial cells into hair cells (Izumikawa et al., 2005), and fibroblasts into 
cardiomyocytes (Qian et al., 2012).  To transform rod photoreceptors into cones, we took 
advantage of the observation that the photoreceptor transcription factor Nrl acts as a cell 
fate switch during development:  photoreceptor precursors that turn on Nrl become rods 
while those that do not become cones (Daniele et al., 2005; Mears et al., 2001).  In this 
study, we found that acute inactivation of Nrl in adult mouse rods caused partial 
reprogramming to the cone phenotype based on molecular, histologic, and functional 
criteria.  Moreover, reprogramming of adult rods achieved cellular and functional rescue 
of retinal degeneration in a mouse model of retinitis pigmentosa. These findings suggest 
that elimination of Nrl in adult rods may represent a novel therapy for retinal 
degeneration. 
 
3.2 Germline Nrl knockout suppresses retinal degeneration in the rd1 mouse 
For an initial proof-of-principle experiment, we hypothesized that developmental 
reprogramming of rod precursors to cones, via germline Nrl knockout, would protect 
photoreceptors from the deleterious effects of a mutation in a rod-specific gene.  To test 
this hypothesis, we created mice with mutations in both Nrl and Pde6b.  Pde6b encodes a 
subunit of phosphodiesterase, a key component of the rod phototransduction cascade 
(Ionita and Pittler, 2007), and Pde6brd1/rd1 mice experience rapid degeneration of nearly 
all rods by the end of the second postnatal week (Carter-Dawson et al., 1978; Sancho-
Pelluz et al., 2008) (Fig. 3.1B).  Knockout of Nrl in the Pde6brd1/rd1 background 
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completely suppressed the degeneration phenotype (Fig. 3.1B), demonstrating that 
developmentally reprogrammed rods are resistant to degeneration. 
 
3.3 Generation and characterization of a conditional Nrl knockout mouse 
To determine whether acute Nrl loss is sufficient to abrogate retinal degeneration during 
adulthood, we next engineered a floxed allele of Nrl to enable conditional inactivation in 
the adult mouse (Fig. 3.2A).  The insertion of loxP sites at the Nrl locus did not affect 
normal retinal development or function, as assessed by H&E histology (Fig. 3.2B), in situ 
hybridization for rod and cone genes (Fig. 3.2B), Nrl and rhodospin protein expression 
(Fig. 3.3A-B), and electroretinogram (ERG) analysis (Fig. 3.4A-B). 
 We next sought to demonstrate that germline knockout of the floxed Nrl allele 
recapitulates the all-cone phenotype of the previously published straight Nrl knockout 
(Mears et al., 2001).  Crossing the Nrl floxed mouse to the Sox2-Cre transgenic line 
elicited transmissible, germline recombination of Nrl (Hayashi et al., 2002).  Nrl 
knockout mice generated in this fashion, termed NrlCKO/CKO, lacked detectable Nrl protein 
(Fig. 3.3B).  There was a total loss of rod-specific genes including Rho, and a 
corresponding derepression of cone genes (Fig. 3.2).  In addition, ERGs demonstrated 
loss of rod function, and a corresponding gain of cone function consistent with functional 
conversion of rods into cones, as previously reported for the straight knockout (Daniele et 
al., 2005) (Fig. 3.4C-D). 
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3.4 Reprogramming adult mouse rods into cone-like cells via Nrl knockout 
To directly test the hypothesis that acute Nrl knockdown in the adult mouse would result 
in reprogramming of rod photoreceptors into cones, we crossed the Nrl floxed mouse to a 
transgenic line carrying a tamoxifen-inducible Cre recombinase (Hayashi and McMahon, 
2002), CAG-CreERTM.  Both experimental (Nrlf/f;CAG-CreERTM) and control mice 
(Nrl+/f;CAG-CreERTM) were injected daily with 4-hydroxytamoxifen (4-OHT) from 
postnatal day 42 (P42) to 44, to induce acute Nrl inactivation.  The animals were 
evaluated three weeks later (Fig. 3.5A), at which point the Nrl transcript and protein 
product were essentially undetectable in the experimental retinas (Fig. 3.5B and 3.6).  
Antibody staining (Fig. 3.5C) and in situ hybridization (Fig. 3.6) revealed that most rod 
genes were downregulated, although some genes such as Rho had residual expression.  
Conversely, several cone genes including Gnat2, Gnb3, and Pde6c were derepressed, but 
the two cone opsins—Opn1mw and Opn1sw—were unaffected (Fig. 3.5C and 3.6).  Next 
we performed electron microscopy to assess morphological changes induced by acute Nrl 
knockout.  In the adult Nrl knockout retina, many rods had larger nuclei, more frequent 
juxtanuclear mitochondria and more abundant euchromatin than controls (Fig. 3.7).  
Thus, the reprogrammed rods displayed a variety of molecular (Corbo et al., 2007) and 
morphological (Carter-Dawson and LaVail, 1979a; Corbo and Cepko, 2005) features of 
cones. 
 To test whether the reprogrammed photoreceptors exhibit cone-like physiology, 
we performed two sets of functional studies.  First, conventional ERGs revealed that 
acute Nrl knockout causes a significant decrease in the retinal response to flashes under 
scotopic conditions, implying loss of rod function (Fig. 3.8A-B).  In contrast, the 
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reprogrammed retinas exhibited a significantly greater maximal photopic a-wave 
response compared to controls, suggesting enhanced cone function (3.8A-B).  The 
reduced rod function in acute Nrl knockout retinas could be directly observed by 
transretinal recordings of the photoreceptor light response (Fig. 3.9A).  Notably, dark-
adapted reprogrammed rods showed a 35-fold desensitization and more rapid inactivation 
of their photoresponse compared with control cells, features reminiscent of cones 
(Heikkinen et al., 2008).   
 Since normal cones, but not rods, can utilize the retinol form of visual 
chromophore to regenerate their photopigment after bleaching (Wang and Kefalov, 
2009), we next tested whether the reprogrammed rods could utilize 9-cis-retinol (a 
commercially available analog of 11-cis-retinol) to regenerate their pigment in a retinal 
explant preparation (Kolesnikov and Kefalov, 2012).  Following overnight dark-
adaptation, mouse retinas were harvested and dissected free of the retinal pigment 
epithelium (RPE) under infrared illumination.  Immediately thereafter, control retinas 
generated robust responses to a series of light stimuli while reprogrammed retinas 
produced a lower maximum response amplitude (Fig. 3.9B).  However, when the 
photopigment was bleached after dissection and the retinas were allowed to re-dark adapt 
in the presence of 9-cis-retinol, only reprogrammed retinas were able regenerate pigment 
and recover their photoresponse (Fig. 3.9B).  Taken together, these findings are 
consistent with cellular and functional reprogramming of rods into cone-like cells in the 
adult Nrl knockout. 
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3.5 Analysis of potential barriers to complete rod-to-cone reprogramming 
Since adult Nrl knockout resulted in an incomplete rod-to-cone transformation, we sought 
to elucidate what factors might inhibit the phenotypic reprogramming.  First, we 
hypothesized that remodeling of certain rod and cone gene loci might simply require 
more time.  Even 11 weeks following acute knockout, however, rod and cone gene 
expression patterns were not different from the patterns observed 3 weeks post-knockout 
(Fig. 3.10A).   
 Second, we hypothesized that persistence of the rod-specific transcription factor 
Nr2e3, even at low levels, might be sufficient to maintain the rod transcriptional program.  
Nr2e3 acts downstream of Nrl and is a well-characterized activator of rod genes and 
repressor of cone genes, including Opn1sw (Chen et al., 2005; Corbo and Cepko, 2005; 
Haider et al., 2009; Peng et al., 2005).  To test this hypothesis, we performed acute Nrl 
knockout on the Nr2e3rd7/rd7 background, which lacks functional Nr2e3 (Akhmedov et al., 
2000; Chen et al., 2006).  Even in the Nr2e3-null context, however, Opn1sw was not 
derepressed in the dorsal retina (Fig. 3.10B; note that derepression of Opn1sw in the 
ventral retina is normally observed in Nr2e3rd7/rd7 mice and therefore is seen in both 
control and experimental animals).   
 Third, we hypothesized that an epigenetic modification, specifically DNA 
methylation, might inhibit complete inactivation of certain rod genes and activation of 
certain cone genes.  Induced pluripotent stem cells (iPSCs) generated by transcription 
factor-based reprogramming have been shown to sustain residual DNA methylation 
patterns reflecting their tissue of origin (Kim et al., 2010; Ohi et al., 2011); these patterns 
are thought to restrict the lineages available for re-differentiation.  To test this hypothesis, 
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we examined the retinal CpG methylation pattern at the Rho and Opn1sw loci in four 
groups of animals at P63:  wild-type (C57BL/6), Nrl-/-, control (one floxed Nrl allele 
recombined at P42), and acute Nrl knockout (two floxed Nrl alleles recombined at P42) 
(Fig. 3.11A-B).  Rho is heavily transcribed in rod but not cone photoreceptors, and the 
locus is relatively unmethylated in the rod-enriched wild-type and control retinas 
compared to the cone-only Nrl-/- retina (Fig. 3.11A).  Importantly, acute Nrl knockout 
failed to induce an increase in methylation at the Rho locus.  Conversely, Opn1sw is 
transcribed only in a subset of mouse cones (including the cones of the Nrl-/- mouse); the 
locus is highly methylated in wild-type and control retinas and less methylated in Nrl-/- 
retinas (Fig. 3.11B).  Acute Nrl knockout did not result in a decrease in methylation at the 
Opn1sw locus.  These results indicate that Nrl knockout during adulthood fails to elicit 
the same gene methylation patterns as Nrl knockout during embryogenesis, and this 
failure may explain the differences in gene expression. 
 Interestingly, the retinal methylation pattern of Opn1sw is established gradually 
during development (Susan Shen, personal communication).  At P0 and P4 in both wild-
type and Nrl-/- retinas, Opn1sw is heavily methylated.  Whereas this methylation level is 
maintained in wild-type retinas, it is steadily lost in Nrl-/- retinas from P7 through P14 (S. 
Shen).  Therefore, we hypothesized that the progressive establishment of the Opn1sw 
methylation pattern correlates with the progressive loss of responsiveness of the Opn1sw 
locus to acute Nrl knockout.  To test this hypothesis, we injected mice with 4-OHT at 
developmental timepoints to induce Nrl knockout, then assessed Opn1sw expression 
three weeks later via in situ hybridization (Fig. 3.12).  Consistent with our hypothesis, 
acute Nrl knockout at P0 and P4 elicited derepression of Opn1sw, while knockout at later 
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timepoints did not.  Thus, acute Nrl knockout at the adult stage results in a partial 
conversion of mouse rods into cones, and the incompleteness of reprogramming may be 
attributable to persistent DNA methylation patterns at certain photoreceptor gene loci. 
 
3.6 Rescue of retinal degeneration in the Rhodopsin null mouse via rod 
reprogramming 
The Rho-/- mouse is a well-established model of retinitis pigmentosa wherein an initial 
period of rod death is followed by secondary cone dysfunction and loss (Jaissle et al., 
2001; Lem et al., 1999) (Fig. 3.13A).  To test the hypothesis that conversion of diseased 
rods into cones, though incomplete, might achieve rescue of retinal degeneration, we 
performed acute Nrl knockout on the Rho-/- background.  We induced acute Nrl knockout 
by injecting Rho-/- mice with 4-OHT between P25 and P28, before the onset of the major 
rod death period (Lem et al., 1999).  Evaluation of rescue was performed at P90, a 
timepoint when rod death is nearly complete and cone dysfunction is advanced (Jaissle et 
al., 2001; Lem et al., 1999) (Fig. 3.13A).   
 We found that acute Nrl knockout does indeed prevent photoreceptor cell death, 
with striking preservation of rod cell bodies (Fig. 3.13B-C).  The reprogrammed Rho-/- 
retinas exhibited a gene expression pattern identical to that of reprogrammed wild-type 
retinas (Fig. 3.14), and cone opsin expression was well preserved (Fig. 3.13 and 3.14).  
Electron microscopy revealed longer photoreceptor inner segments in reprogrammed 
retinas relative to controls, although outer segments were not readily apparent (Fig. 3.15).  
Most importantly, the histologic and molecular rescue was accompanied by robust rescue 
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of cone function, as ERG analysis revealed an intact photopic b-wave over a wide range 
of flash intensities (Fig. 3.16A-B). 
 
3.7 Reprogramming and rescue via AAV-delivered Nrl RNAi 
To serve as a practical therapy for retinitis pigmentosa in humans, Nrl knockdown must 
be deliverable to the retina via viral transduction or other similar means.  We therefore 
created an adeno-associated virus (AAV) containing an shRNA construct targeting Nrl 
('Nrl RNAi') as well as a CAG-GFP cassette to trace the infection.  The pseudotyped 
AAV-2/5 vector was chosen because of its strong photoreceptor tropism; the onset of 
transgene expression is approximately two weeks following subretinal delivery (Allocca 
et al., 2007; Auricchio et al., 2001).  The Nrl RNAi construct, driven by the U6 promoter, 
was previously published and shown to cause efficient Nrl knockdown and 
downregulation of Nrl target genes such as Rho (Matsuda and Cepko, 2004).  
 To test whether Nrl knockdown could recapitulate the gene expression changes 
induced by acute genetic ablation, the AAV-Nrl RNAi-CAG-GFP virus was injected into 
the subretinal space of P22 C57BL/6 mice.  The retinas were harvested three weeks later 
and in situ hybridizations were performed for rod and cone genes.  Infected areas showed 
downregulation of rod genes and derepression of certain cone genes (Fig. 3.17), as 
observed with genetic Nrl knockout.  However, expression of both cone opsins (Opn1mw 
and Opn1sw) was markedly reduced.  The cause of cone opsin loss is unknown, although 
one group has reported AAV-related cone toxicity that may be attributable to GFP 
overexpression (Beltran et al., 2010).   
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 Rho-/- mice were then injected subretinally with AAV-Nrl RNAi-CAG-GFP 
between P20-22, and the retinas were evaluated at P90.  Retinal patches infected with the 
virus showed significant preservation of rods compared to both uninfected areas and 
patches infected with a scrambled RNAi-containing control virus (Fig. 3.18A-C).  
Although functional cone preservation was not achieved in this experiment (data not 
shown), the significant cellular rescue suggests that viral-delivered Nrl RNAi has 
therapeutic potential. 
 
3.8 Discussion 
In this study, we have shown that acute knockdown of Nrl in the adult mouse retina 
causes partial reprogramming of rod photoreceptors into cones.  The reprogrammed rods 
exhibit certain molecular, morphological, and functional characteristics of cones, with 
notable exceptions including the lack of Opn1sw derepression and the relatively normal 
photopic ERG.  Nevertheless, partial conversion of rod photoreceptors was sufficient to 
prevent photoreceptor cell death in the Rho-/- model of retinitis pigmentosa. 
 While the role of Nrl in rod photoreceptor development has been well 
characterized (Akimoto et al., 2006; Daniele et al., 2005; Mears et al., 2001; Oh et al., 
2007), this study is the first to elucidate the functional importance of Nrl in the 
maintenance of the rod phenotype.  We found that Nrl is essential for the transcription of 
certain rod genes in adult mice, including Gnat1 and Gnb1.  Other rod genes are 
downregulated upon acute Nrl knockout yet not completely absent, including Rho, 
Pde6a, Pde6b and Nr2e3.  Conversely, certain cone genes like Gnb3, Gnat2, and Pde6c 
are derepressed upon acute Nrl ablation, while others like Opn1sw remain unchanged 
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(Fig. 3.6).  Thus, photoreceptor genes exhibit differing degrees of ‘responsiveness’ to Nrl 
knockout at the adult stage. 
 What factors might account for this variability?  First, Nrl may help establish 
epigenetic modifications at particular loci during photoreceptor differentiation, and these 
modifications may later preserve locus activation or repression independently of Nrl.  We 
have shown here that the DNA methylation patterns at two refractory loci, Rho and 
Opn1sw, remain unchanged following acute Nrl knockout (Fig. 3.11).  Since DNA 
methylation is highly correlated with transcriptional activity (reviewed in Deaton and 
Bird, 2011), this may explain why Rho and Opn1sw transcript levels remain relatively 
unchanged.  In this study, we attempted to induce Opn1sw derepression via simultaneous 
Nrl knockdown and AID overexpression.  AID (activation-induced cytidine deaminase) 
is an enzyme that has been shown to participate in active DNA demethylation (reviewed 
in Fritz and Papavasiliou, 2010).  Delivery of AID via subretinal AAV injection did not 
induce Opn1sw derepression (data not shown), and it is currently unclear whether AID 
failed to induce demethylation at Opn1sw or whether demethylation was simply 
inadequate to trigger Opn1sw expression.  In addition to DNA methylation, histone 
modifications may also participate in the maintenance of gene expression or silencing 
following differentiation.  Further studies will be required to elucidate the role of both 
activating and silencing histone modifications on the Nrl-independent maintenance of 
photoreceptor gene expression.   
 Second, it is possible that Nrl may activate an unknown transcription factor ‘X’ 
during development.  ‘X’ may then activate a subset of rod genes (for example, Rho but 
not Gnat1) and repress a subset of cone genes (Opn1sw but not Gnb3).  If expression of 
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‘X’ becomes independent of Nrl during adulthood, via autoregulation for instance, then 
‘X’ may maintain its regulatory function even following acute Nrl knockout.  During this 
study, we identified the rod-specific transcription factor Nr2e3 as a potential candidate 
for ‘X’.  However, acute Nrl knockout on the Nr2e3-null background failed to elicit 
derepression of Opn1sw (Fig. 3.10B).  Thus, another unknown transcription factor or 
factors downstream of Nrl may inhibit complete rod-to-cone transdifferentiation at the 
molecular level. 
 Third, acute Nrl knockout may fail to activate cone transcription factors required 
for the expression of genes such as the cone opsins.  Activation of these factors may 
depend on environmental cues present during development but not adulthood.  TRβ2, for 
example, has been shown to promote M-opsin expression at the expense of S-opsin (Ng 
et al., 2001) in the presence of the thyroid hormone T3 (Applebury et al., 2007).  Sall3, in 
contrast, appears to activate expression of S-opsin during retinal development (de Melo et 
al., 2011).  In adult mouse retinas, we attempted unsuccessfully to induce (a) ectopic M-
opsin expression via simultaneous Nrl knockdown and TRβ2 overexpression, and (b) 
ectopic S-opsin expression via simultaneous Nrl knockdown and Sall3 overexpression 
(data not shown).  The failure of simple transcription factor overexpression to activate 
cone opsin may attest to the complexity of M- and S-opsin regulation during 
development.  This regulatory pathway involves numerous other transcription factors 
including RORα (Fujieda et al., 2009), RORβ (Srinivas et al., 2006), and RXRγ (Roberts 
et al., 2005), and post-translational modifications of these factors may also play important 
roles (Onishi et al., 2010). 
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 One interesting feature of the reprogrammed retinas is that the rod transducin α-
subunit (Gnat1) appeared to be completely gone at both the transcript and protein level 
(Fig. 3.5C and 3.6), yet the retinas still generated a modest scotopic ERG signal (Fig. 
3.8).  Gnat1 mutant mice, in contrast, completely lack a rod-driven photoresponse 
(Calvert et al., 2000).  This prompts speculation that derepressed cone transducin α-
subunit (Gnat2) may be substituting for the rod subunit in reprogrammed rod 
photoreceptors.  Indeed, a previous study demonstrated that the rod and cone transducin 
α-subunits are functionally interchangeable in photoreceptors, with comparable signaling 
properties (Deng et al., 2009).  Expression levels of the other transducin subunits (β and 
γ) were not as dramatically altered as the α-subunit according to microarray data (not 
shown), so it would be interesting to determine whether the cone α-subunit might be 
associating with the rod β and γ subunits in reprogrammed rod photoreceptors. 
 Despite the incompleteness of rod-to-cone reprogramming, an interesting 
consequence of acute Nrl knockout was the gain of cone-like physiological properties.  
Two of these features, the reduced scotopic ERG (Fig. 3.8) and 35-fold desensitization 
during isolated transretinal recording (Fig. 3.9A), are likely due to a substantial decrease 
in the expression of rod-specific phototransduction components including rhodopsin, rod 
transducin, and rod phosphodiesterase.  Additionally, isolated reprogrammed retinas 
exhibited faster inactivation of the photoresponse (Fig. 3.9A).  Fast inactivation is a 
hallmark of cone phototransduction (Tachibanaki et al., 2001), and Nrl-/- cones exhibit 
this property as well (Daniele et al., 2005; Nikonov et al., 2005).  In some species 
including carp and zebrafish, faster inactivation of phototransduction in cones relative to 
rods is achieved via a highly efficient, cone-specific opsin kinase, GRK7 (Tachibanaki et 
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al., 2005; Wada et al., 2006).  Since mice express only a single opsin kinase in both rods 
and cones (GRK1; Weiss et al., 2001), the inactivation kinetics must also be modulated 
by other unknown factors (Nikonov et al., 2005).  These factors appear to be functional in 
both Nrl-/- cones and rods reprogrammed by acute Nrl knockout.   
 Another important gain-of-function phenotype in reprogrammed rods is their 
ability to utilize an 11-cis retinol analog to regenerate their visual pigment.  This capacity 
is normally a feature of cones and not rods.  The ability of cones to convert 11-cis retinol 
into 11-cis retinal makes it possible for them to access the visual cycle in which Müller 
glia convert all-trans retinol into 11-cis retinol via a series of enzymatic reactions, as 
demonstrated in the salamander, mouse, primate, and human (Wang et al., 2009; Wang 
and Kefalov, 2009).  The fact that reprogrammed rods are able to regenerate pigment and 
dark-adapt by utilizing 9-cis retinol (an analog of 11-cis retinol) (Fig. 3.9B) implies that 
acute Nrl knockout induces expression of a factor, possibly a dehydrogenase, that can 
mediate conversion of 11-cis retinol (or 9-cis retinol) to the retinal form.  Further 
experiments would be required to determine the identity of this enzyme.  
 Apart from providing some insights into the plasticity and maintenance of 
photoreceptor identity, this study has demonstrated that partial rod-to-cone 
reprogramming can forestall retinal degeneration in the Rho-/- model of retinitis 
pigmentosa (Fig. 3.13 and 3.18).  At this time, we are unsure of the mechanism 
underlying the preservation of reprogrammed rod photoreceptors.  These cells are not 
true cones, yet they may exhibit sufficient downregulation of rod-specific genes to 
become immune from the deleterious effects of mutations in these genes.  Interestingly, 
the rod gene expression changes induced by acute Nrl knockout are similar to those 
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observed following treatment of the retina with ciliary neurotrophic factor, or CNTF 
(Wen et al., 2006).  This suggests that these two manipulations, acute Nrl knockout and 
CNTF delivery, may preserve rod photoreceptors via a related pathway.  The 
neuroprotective mechanism of CNTF is unclear, but one hypothesis is that 
downregulation of the rod phototransduction machinery reduces the metabolic stress on 
cells prone to degeneration (reviewed in Wen et al., 2012).  It will be necessary to test 
acute Nrl knockout in other models of retinitis pigmentosa, including models of 
autosomal dominant disease (Price et al., 2011), to determine whether it is a truly 
universal therapy for retinal degeneration caused by mutations in rod-specific genes. 
 
3.9 Materials and methods 
 
Animals 
The following mouse strains were maintained on a 12-h light-dark schedule at 20-22oC, 
with free access to food and water:  Nrl-/- (Mears et al., 2001), Rho-/- (Lem et al., 1999), 
C57BL/6 (Taconic, Hudson, New York), Sox2-Cre (Jackson Laboratories, Bar Harbor, 
Maine), Pde6brd1 (Jackson Laboratories), CAG-CreERTM (Hayashi and McMahon, 2002), 
Nrl floxed, and Nrl CKO.  All experiments were conducted in accordance with the Guide 
for the Care and Use of Laboratory Animals and the Animal Welfare Act and were 
approved by the Washington University in St. Louis Institutional Care and Use 
Committee (approval no. 20110089). 
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 To generate the Nrl floxed mouse, a targeting vector was constructed using 
recombineering methods (Lee et al., 2001).  Briefly, a genomic region encompassing 9.1 
kb of the Nrl locus was subcloned from BAC RP23-90H9 (CHORI, Oakland, California) 
into a modified pBluescript vector.  A loxP site was inserted 240 bp downstream of Nrl 
exon 3, and a loxP-flanked neo cassette was inserted 122 bp downstream of exon 2.  The 
construct was linearized with NotI prior to transfection into SCC10 embryonic stem (ES) 
cells.  Successful transformants were confirmed by Southern blotting and karyotyped.  
The floxed neo cassette was then removed by transient transfection with Cre 
recombinase, and ES cells were injected into C57BL/6 blastocysts for chimera 
production.  Genotyping primers for the Nrl floxed allele are listed in Table 3.1. 
 To generate the Nrl CKO mouse, the Nrl floxed line was crossed to the deleter 
strain Sox2-Cre (Hayashi et al., 2002).  Genotyping primers for the recombined Nrl allele 
are listed in Table 3.1. 
 To induce Cre recombinase activity in mice carrying the CAG-CreERTM transgene, 
animals were injected intraperitoneally, daily for three consecutive days, with 0.75 mg 4-
hydroxytamoxifen (4-OHT; Sigma) dissolved in 15% ethanol / 85% corn oil.  The 
reprogramming or control phenotypes were confirmed in all animals via in situ 
hybridization for Nrl, Gnat1, Gnb3, and Opn1sw.  A number of animals exhibited 
spontaneous, tamoxifen-independent induction of Cre recombinase activity during 
development, evidenced by patchy derepression of Opn1sw in the ONL of both 
tamoxifen- and vehicle-treated Nrlf/f;CreERTM and Rho-/-;Nrlf/f;CreERTM animals; all data 
from these animals were discarded. 
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Histology and staining 
For immunohistochemistry and in situ hybridizations (ISH), retinas were dissected in 
PBS and fixed in 4% paraformaldehyde for 30 min at room temperature.  Tissue was 
equilibrated in 30% sucrose overnight prior to embedding in Tissue-Tek OCT compound 
(Sakura, Torrance, California).  Frozen blocks were sectioned at a thickness of 12 μm.  
For H&E staining, whole eyes were fixed in 4% paraformaldehyde overnight at 4oC.  
Eyes were dehydrated to 100% ethanol, embedded in paraffin, and sectioned at a 
thickness of 4 μm.  H&E staining was performed by standard methods. 
 For antibody staining, frozen sections were blocked in 5% normal donkey serum / 
0.1% triton X-100 for 1 h at room temperature (RT).  Sections were incubated in primary 
antibody overnight at 4oC.  Following PBS rinses, sections were incubated in secondary 
antibody (1:800, Alexa Fluor 555 donkey anti-rabbit or donkey anti-mouse; Invitrogen) 
for 30 min at RT, DAPI-stained, and coverslipped with Vectashield mounting medium 
(Vector Labs, Bulingame, California).  Primary antibodies used were a polyclonal anti-
blue opsin raised in rabbit (1:200, Millipore), a polyclonal anti-red/green opsin raised in 
rabbit (1:600, Millipore), a polyclonal anti-rod transducin α-subunit raised in rabbit 
(1:1500, Santa Cruz Biotechnology), and a mouse monoclonal anti-rhodopsin antibody 
(Rho4D2; 1:600, kind gift from Dr. Cheryl Craft).  Confocal image stacks were captured 
using a BX61 WI microscope (Olympus) equipped with a DSU spinning disc and an 
ORCA-ER CCD camera (Hamamatsu).  Image stacks were processed using SlideBook 
software (Intelligent Imaging Innovations, Denver, Colorado) and Photoshop CS4 
(Adobe). 
 77
 ISH was performed on frozen retinal sections as previously described (Chen and 
Cepko, 2000).  RNA riboprobes were synthesized from PCR templates previously 
described (Corbo et al., 2007) with the exception of probes for Nrl, Nr2e3, Gnat2, and 
Pde6c.  Templates for the latter probes were generated by PCR from mouse retinal cDNA 
using primers listed in Table 3.1. 
 For electron microscopy, eyecups were fixed by immersion for 12-24 h in 2% 
paraformaldehyde, 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.35), post-fixed in 
1% osmium tetroxide for 1 h and stained en bloc with 1% uranyl acetate in 0.1 M acetate 
buffer for 1 h.  Blocks were then dehydrated in a graded series of water-based acetone 
solutions and embedded in Araldite 6005/Embed 812 resin.  Semi-thin sections (0.5-1 
μm) were cut through the entire retina at the level of the optic nerve.  Ultra-thin sections 
were taken from the first 600-800 μm of tissue adjacent to the optic nerve, post-stained 
with uranyl acetate and lead citrate, and viewed on a Hitachi H7500 electron microscope.  
Image montages were generated using Photoshop CS4. 
 
Quantification of ONL cells 
H&E-stained paraffin sections (Rho-/-;Nrlflox;CreERT) or DAPI-stained frozen sections 
(AAV-treated Rho-/-) were imaged at 400X magnification and cropped to a retinal length 
of 300 μm.  Cell bodies in the ONL were counted using ImageJ software (Rasband, 1997) 
and the Cell Counter plugin (Kurt de Vos, University of Sheffield).  For Rho-/-
;Nrlflox;CreERT animals, two central fields per animal were counted and averaged.  For 
AAV-treated Rho-/- animals, one GFP(+) and one GFP(-) field per animal were counted.  
Statistical analysis was performed using GraphPad Prism 5 software. 
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Western blot analysis 
One retina from each animal was dissected and immersed in 200 μl of modified RIPA 
buffer (65 mM Tris base, 154 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium 
deoxycholate, 1 mM PMSF, 1% protease inhibitor Sigma P8340, 1% phosphatase 
inhibitor Sigma P2850; pH 7.4).  Tissue was lysed via sonication and centrifuged at 4oC. 
Protein in the supernatant was quantified using the BCA Protein Assay Kit (Thermo 
Fisher Scientific).  An equal amount of protein from each sample was loaded on a 10% 
Bis-Tris SDS-PAGE gel (Invitrogen), separated by electrophoresis, and transferred to a 
nitrocellulose membrane (Whatman).  Membranes were blocked for 1 h at RT in the 
following solutions: for the rhodopsin antibody, 5% nonfat dry milk in 1X TBST (150 
mM NaCl, 10 mM Tris pH 8.0, 0.1% Tween-20); for the Nrl antibody, 5% normal 
donkey serum in 1X TBST.  Membranes were incubated in the following primary 
antibodies overnight at 4oC:  mouse monoclonal anti-rhodopsin antibody Rho4D2 
(1:10,000; kind gift from Dr. Cheryl Craft) or goat polyclonal anti-Nrl antibody (1:500; 
R&D Biosystems, Minneapolis, Minnesota).  Secondary antibody incubation was 
performed for 1 h at RT in horseradish peroxidase (HRP)-conjugated goat anti-mouse 
(1:10,000, Thermo Fisher Scientific) or donkey anti-goat (1:5000, Thermo Fisher 
Scientific).  Membranes were treated with ECL reagent (Thermo Fisher Scientific) per 
manufacturer instructions, exposed to x-ray film for detection, and stripped of the 
primary antibodies using mild stripping buffer (200 mM glycine, 0.1% SDS, 1% Tween-
20; pH 2.2).  Following 1 h block at RT in 5% BSA / 1X TBST, membranes were re-
probed with anti-β-tubulin (1:10,000; Sigma) overnight at 4oC. Membranes were 
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incubated in HRP-conjugated goat anti-mouse (1:5000, Thermo Fisher Scientific) for 1 h 
at RT and developed as previously stated. 
 
Bisulfite methylation analysis 
One retina from each animal was dissected in PBS, and genomic DNA was purified from 
minced retinal tissue using the Gentra Puregene kit (Qiagen).  Bisulfite conversion of 
retinal DNA was performed with the EpiTect Bisulfite Kit (Qiagen).  The Rho locus (-
298 to +202 relative to the transcription start site) and Opn1sw locus (-4 to +473) were 
amplified from bisulfite-converted DNA using primers listed in Table 3.1, and the PCR 
products were cloned into the pCR4-TOPO vector (Invitrogen) per manufacturer 
instructions.  Individual clones were purified and sequenced by Beckman Coulter 
Genomics (Danvers, Massachusetts) using the T3 primer. 
 Clones with >95% bisulfite conversion rate were analyzed using BISMA software 
(Rohde et al., 2010) to retrieve the percent methylation of individual CpG’s.  Fig. 3.11 
was assembled using data generated by BISMA and graphics generated by CpGviewer 
(Carr et al., 2007) and Photoshop CS4. 
 Two biological replicates were processed for each genotype, and each biological 
replicate produced 11-24 acceptable sequences.  
 
Electroretinography 
ERGs were performed as described in (Kolesnikov et al., 2011) with minor 
modifications.  For the scotopic ERG, a digital 60-Hz notch filter was used to reduce 
noise interference at the three lowest flash intensities.  For the photopic ERG, mice were 
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light-adapted for 10 min, and test flashes were applied in the presence of dim (29 cd/mm) 
background illumination.  All test flashes were 10 μs in duration, and 5-10 responses 
were averaged per flash intensity.  Statistical analysis was performed using GraphPad 
Prism 5 software. 
 
Recordings from isolated retinas 
Mice were dark-adapted overnight and sacrificed by CO2 asphyxiation and cervical 
dislocation.  Retinas were removed under infrared illumination and stored in oxygenated 
aqueous L15 solution (13.6 mg/ml, pH 7.4, Sigma) containing 0.1% BSA, at RT.  Prior to 
recording, the retina was mounted on filter paper with the photoreceptor side up and 
placed in the recording chamber.  One electrode was connected to the bottom of the 
perfusion chamber, and a second electrode was placed just above the center of the retina.  
The retina was perfused throughout the recording session with Locke’s solution (112.5 
mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 10 mM HEPES pH 7.4, 20 mM 
NaHCO3, 3 mM Na succinate, 0.5 mM Na glutamate, 0.02 mM EDTA, 10 mM glucose).   
The solution was supplemented with 2 mM L-glutamate and 10 µM DL-AP-4 to block 
higher order components of the photoresponse (Sillman et al., 1969a, b), with 20 µM 
BaCl2 to suppress the glial component (Nymark et al., 2005), and with MEM vitamins 
and MEM amino acid solutions (Sigma) to improve retina viability.  The perfusion 
solution was bubbled continuously with 95% O2 / 5% CO2 mixture and heated to 36–
37°C.  The electrode solution (140 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM 
CaCl2, 3 mM HEPES, 10 mM glucose; pH 7.4) in the lower electrode space also 
contained 2 mM L-glutamate and 10 mM BaCl2. 
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 Near-complete bleaching of the visual pigment was performed on a filter paper-
mounted retina placed in a small Petri dish.  The retina was exposed for 2 min to a 100 W 
halogen bulb light source coupled to a 520 nm interference filter.  The retina was then 
allowed to dark-adapt for 2.5 h at RT, in L15 solution with or without 9-cis-retinol (final 
concentration 130 µM, with 0.1% ethanol and 1% BSA added), in a dark box saturated 
with pure oxygen.  Following dark adaptation the retina was placed in the recording 
chamber as described above. 
 Light stimulation was applied by 20 ms test flashes of calibrated 505-nm LED 
light.  For light uniformity, a glass optical diffuser was placed between the LED and the 
retina.  The stimulating light intensity was controlled by neutral density filters and a 
computer in 0.5 log unit steps.  Photoresponses were amplified by a differential amplifier 
(DP-311; Warner Instruments), low-pass filtered at 30 Hz (8-pole Bessel), digitized at 1 
kHz and stored on a computer for further analysis.  Half-saturating light intensity (I1/2) 
was calculated from the intensity-response relation for each retina as the test flash 
intensity required to produce a response with an amplitude equal to half of the 
corresponding saturated response amplitude.  Integration time (Tintegr.) was calculated as 
the integral of the dim flash response with the transient peak amplitude normalized to 
unity.  The time constant of the dim flash response recovery (τrec) was derived from 
single-exponential fit to the falling phase of the response.  Data were analyzed using 
Clampfit 10.2 and Origin 8.5 software. 
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Construction of AAV vectors 
The Nrl RNAi expression construct pBSU6-Nrl RNAi has been previously described 
(Matsuda and Cepko, 2004).  To create the scrambled RNAi expression construct, 
pBSU6-Scrambled RNAi, the nucleotides of the Nrl RNAi targeting arm were 
randomized and screened with BLAST (NCBI) to confirm that the new sequence did not 
target any known mouse genes.  Oligonucleotides encoding an shRNA construct with the 
scrambled sequence (Table 3.1) were annealed and inserted into the pBS/U6 vector (Sui 
et al., 2002) digested with ApaI (blunted) and EcoRI.  
 pBSU6-Nrl RNAi or pBSU6-Scrambled RNAi, digested with PvuII and KpnI, 
was inserted into the AAV-2 expression vector pTR-UF11 (kind gift from Dr. William 
Hauswirth), digested with SalI (blunted) and KpnI, to create AAV-RNAi.  CAG-GFP 
(Matsuda and Cepko, 2004) was then digested with ApaLI (blunted) and HindIII 
(blunted) and inserted into AAV-RNAi, digested with SalI (blunted), to create AAV-Nrl 
RNAi-CAG-GFP or AAV-Scrambled RNAi-CAG-GFP. 
 AAV-Nrl RNAi-CAG-GFP and AAV-Scrambled RNAi-CAG-GFP were 
packaged into the AAV-5 viral capsid by the Hope Center Viral Core (Washington 
University School of Medicine) to generate an AAV-2/5 virus.  Viral titers were 
measured by dot blot. 
 
Subretinal injections 
Mice were anesthetized with a subcutaneous injection of ketamine (80 mg/kg) / xylazine 
(20 mg/kg), and proparacaine ophthalmic solution (Falcon Pharmaceuticals, Fort Worth, 
Texas) was applied to the cornea.  Under a dissecting microscope at low power, the 
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mouse eye was gently proptosed and a sterile 30G needle was used to puncture the sclera 
just beneath the corneal margin.  A Hamilton syringe with blunt-tipped 32G needle, 
containing 1 μl AAV-Nrl RNAi-CAG-GFP (2.6 x 1012 vg/ml) or AAV-scrambled RNAi-
CAG-GFP (1.2 x 1012 vg/ml), was inserted through the hole and advanced through the 
vitreous chamber until the needle was in the subretinal space.  The viral solution was then 
injected.  Following injection, Vetropolycin ointment (Pharmaderm, Melville, New York) 
was applied to the cornea.  Typically, one eye was injected with AAV-Nrl RNAi-CAG-
GFP and the other eye was injected with AAV-Scrambled RNAi-CAG-GFP. 
 
 
 Figure 3.1:  Rod reprogramming therapy.  (A) Hypothesis that the normal progression 
of photoreceptor degeneration in retinitis pigmentosa might be circumvented by 
reprogramming of rods into cones via acute Nrl knockout.  (B) Mice homozygous for the 
mutant rd1 allele of rod-specific Pde6b have lost nearly all rod photoreceptors by P36.  
Germline deletion of Nrl on the Pde6brd1/rd1 background suppresses the degeneration 
phenotype.  ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.   
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 Figure 3.2:  Engineering a conditional allele of Nrl.  (A) Schematic of the conditional 
Nrl allele; the first coding exon (ex3) is flanked by loxP sites.  (B) Nrlf/f retinas are 
indistinguishable from wild-type retinas by H&E histology and staining for a variety of 
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rod and cone transcripts at P63.  A straight Nrl knockout mouse, NrlCKO/CKO, was created 
by crossing the Nrl floxed mouse to the Sox2-Cre transgenic line which causes germline 
recombination (Hayashi et al., 2002).  Photoreceptor gene expression patterns in the 
NrlCKO/CKO and canonical Nrl-/- mice (Mears et al., 2001) are identical. 
  
Figure 3.3:  Nrl and rhodopsin protein expression in Nrlf/f and NrlCKO/CKO retinas.  
(A)  Rhodopsin protein is present in the outer segments of Nrlf/f but not NrlCKO/CKO retinas 
at P63.  (B) Western blot of protein isolated from whole retinas reveals similar levels of 
Nrl and rhodopsin in Nrl+/+ and Nrlf/f retinas.  NrlCKO/CKO retinas, in contrast, lack both 
Nrl and rhodopsin protein.  β-tubulin, loading control. 
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 Figure 3.4:  Electroretinogram analysis of Nrlf/f and NrlCKO/CKO mice.  (A)-(B) ERGs 
recorded from Nrl+/+ and Nrlf/f mice at P63 revealed no significant differences in 
photoresponsiveness at any flash intensity under scotopic and photopic conditions (n = 7 
mice per genotype).  (C)-(D) ERGs recorded from Nrl+/CKO (n = 5) and NrlCKO/CKO (n = 6) 
mice at P63 revealed a significant decrease in the NrlCKO/CKO response to flashes under 
scotopic conditions, implying loss of rod function.  Under photopic conditions, however, 
the NrlCKO/CKO retinas exhibited a larger response to flashes than the controls, consistent 
with increased cone function as previously reported for the Nrl-/- mouse (Mears et al., 
2001).  P values for 2-way ANOVA: *P<0.05, **P<0.01, ***P<0.001.  Error bars, s.e.m. 
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 Figure 3.5:  Acute Nrl knockout in adult mice.  (A) Timeline for the acute Nrl 
knockout experiments presented in this figure.  Animals were injected with 4-
hydroxytamoxifen (4-OHT) daily for three days starting at P42, to induce CreERTM 
activity.  Phenotypes were evalued three weeks later at P63.  Unless otherwise specified, 
control is Nrl+/f;CreERTM + 4-OHT and acute Nrl knockout is Nrlf/f;CreERTM + 4-OHT.  (B) 
Three weeks following acute Nrl knockout, Nrl protein is nearly gone from whole retinal 
extracts, while rhodopsin protein is decreased.  β-tubulin, loading control.  (C) The ONL 
remains intact following acute Nrl knockout, albeit with a variably wavy appearance.  By 
antibody staining for outer segment proteins, rod transducin (alpha subunit, encoded by 
Gnat1) is drastically reduced while other proteins as not as affected. 
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 Figure 3.6:  Acute Nrl knockout induces changes in the expression pattern of specific 
photoreceptor genes.  Three weeks following acute Nrl knockout, in situ hybridization 
reveals downregulation of numerous rod-specific transcripts, although low expression 
levels persist for certain genes such as Rho.  Conversely, a number of cone genes (Gnat2, 
Gnb3, and Pde6c) were derepressed.  Notably, however, the Opn1sw expression pattern 
remained unchanged following acute Nrl knockout. 
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 Figure 3.7:  Electron microscopy reveals cone-like morphological features of 
reprogrammed rod nuclei.  Compared to photoreceptor nuclei in the control animal 
(Nrlf/f;CreERTM + vehicle), reprogrammed photoreceptor nuclei (Nrlf/f;CreERTM + 4-OHT) 
are larger, contain more abundant euchromatin, and possess more frequent juxtanuclear 
mitochondria, which are morphological features reminiscent of cones.  Scale bars, 2 μm. 
 91
 Figure 3.8:  Electroretinogram analysis of animals subjected to acute Nrl knockout.  
(A) Acute Nrl knockout mice (n = 8) had significantly lower a-wave and b-wave 
amplitudes under scotopic conditions than control mice (n = 10).  The photopic response 
was mostly unchanged except for a significantly higher a-wave response to the highest 
flash intensity in acute Nrl knockout mice relative to controls.  P values for 2-way 
ANOVA: **P<0.01, ***P<0.001.  Error bars, s.e.m.  (B) Representative ERG 
waveforms. 
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 Figure 3.9:  Transretinal recordings of control and acute Nrl knockout retinas.  (A) 
Families of responses to increasing light intensities for dark-adapted, isolated control and 
acute Nrl knockout retinas.  Red trace, photoresponses to a light intensity of 392 photons 
μm-2 (505 nm).  (B) Responses to 505 nm test-flashes recorded from isolated retinas, 
lacking RPE, under various conditions (n ≥ 3 animals per condition).  Bleach, exposed to 
520 nm light for 2 min followed by dark-adaptation for 2.5 h.; 9-cis-ROL, the 2.5 h dark-
adaptation was conducted in the presence of 130 µM 9-cis-retinol.  Data were fitted with 
the Naka-Rushton hyperbolic function.  Error bars, s.e.m. 
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Figure 3.10:  Time and residual Nr2e3 expression do not account for the 
incompleteness of rod-to-cone transdifferentiation.  (A) Control and acute Nrl 
knockout retinas were evaluated via in situ hybridization 11 weeks following Cre 
induction, and Opn1sw expression was still unchanged.  (B) Acute Nrl knockout was 
induced on the rd7 background, which lacks functional Nr2e3.  Opn1sw was not 
derepressed in the dorsal retina as it is in the developmental Nrl knockout.  Note that 
derepression of Opn1sw in the ventral retina is normally observed in the Nr2e3rd7/rd7 
mouse. 
 Figure 3.11:  Epigenetic barriers to reprogramming of rods into cones.  Retinal DNA 
methylation status of the Rho (A) and Opn1sw (B) loci for four genotypes, C57BL/6 
(wild-type), Nrl-/-, control (Nrl+/f;CreERT2 + 4-OHT) and acute Nrl knockout 
(Nrlf/f;CreERT2 + 4-OHT).  Each circle represents a single CpG; shading indicates 
percentage methylation across ≥ 28 clones (from two biological replicates).  Graph at 
right represents overall locus methylation; error bars, s.d.  Phastcons, vertebrate 
phylogenetic conservation track from UCSC Genome Browser (Rhead et al., 2010). 
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 Figure 3.12:  The Opn1sw locus gradually becomes refractory to Nrl knockout 
during development.  Mice were injected with 4-OHT to induce Nrl knockout at various 
developmental timepoints, and the Opn1sw transcript was detected three weeks later by 
in situ hybridization.  Nrl knockout at P0 and P4 causes partial derepression of Opn1sw in 
the ONL, but knockout at later timepoints fails to elicit Opn1sw derepression.  Images 
depict the dorsal retina, which has sparse Opn1sw expression in wild-type mice. 
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 Figure 3.13:  Partial reprogramming of rods into cones rescues retinal degeneration.  
(A) Timecourse of photoreceptor degeneration in Rho-/- retinas (top) and timeline for 
acute Nrl knockout experiments on the Rho-/- background (bottom).  Control is Rho-/-
;Nrl+/f;CreERTM + 4-OHT and acute Nrl knockout is Rho-/-;Nrlf/f;CreERTM + 4-OHT.  (B) 
H&E and antibody staining show increased preservation of the ONL and cone opsin 
expression in Rho-/- animals treated with acute Nrl knockout relative to controls.  (C) 
Quantification of ONL cells in 300-μm segments of retina (n = 3 animals per genotype).  
***P<0.001 by unpaired t-test.  Error bars, s.d. 
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 Figure 3.14:  Analysis of photoreceptor 
gene expression in Rho-/- animals with 
acute genetic ablation of Nrl.  Control 
(Rho-/-;Nrl+/f;CreERTM) and acute Nrl 
knockout animals (Rho-/-;Nrlf/f;CreERTM) 
were treated with 4-OHT at P25-28 and 
sacrificed at P90.  Gene expression 
patterns were evaluated via in situ 
hybridization. 
 99
 Figure 3.15:  Electron micrograph montages of Rho-/- retinas treated with acute Nrl 
knockout.  Compared to the control, the rescued retina has greater preservation of the 
ONL (marked by dashed lines).  The photoreceptor inner segments are also longer.  Scale 
bar, 4 μm. 
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 Figure 3.16:  Rho-/- retinas treated with acute Nrl knockout have preserved cone 
function.  (A) Photopic ERGs recorded from control (n = 10) and acute Nrl knockout 
mice (n = 10) on the Rho-/- background.  The b-wave amplitude was significantly greater 
in the acute knockout mice relative to controls.  P values for 2-way ANOVA: **P<0.01, 
***P<0.001.  Error bars, s.e.m.  (B) Representative ERG waveforms. 
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Figure 3.17:  AAV-delivered Nrl RNAi recapitulates the gene expression changes 
induced by acute Nrl knockout.  Wild-type (C57BL/6) mice were injected subretinally 
at P22 with an adeno-associated virus delivering Nrl RNAi and GFP, AAV-Nrl RNAi-
CAG-GFP.  Animals were sacrificed at P43 and retinal gene expression changes were 
analyzed by in situ hybridization. 
 Figure 3.18:  AAV-delivered Nrl RNAi rescues photoreceptor cell bodies in Rho-/- 
mice.  (A)-(B) Rho-/- mice were injected subretinally with an adeno-associated virus 
delivering either a scrambled RNAi control construct (A) or the Nrl RNAi construct (B) 
between P20-P22.  Mice were sacrificed at P90, and retinal sections were stained with 
DAPI to visualize cell bodies.  (C) Retinal areas infected with AAV-Nrl RNAi, but not 
AAV-Scrambled RNAi, had greater preservation of the ONL compared to non-infected 
areas (n ≥ 5 retinas per condition). P values for unpaired t-test: *P<0.05, ***P<0.001. 
Error bars, s.d.   
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Description Sequence (5’-3’) PCR prod. 
Nrl flox genotyping, F 
Nrl flox genotyping, R 
TGGAAGGGCCTCTTGGCTACTATT 
AAAGCGATCTAGCCAGGCAGTGAT 
Floxed 475 bp 
WT 381 bp 
Nrl CKO genotyping, F 
Nrl CKO genotyping, R 
ATCCCTGCAGTCTGCCTCTA 
CACAGCTCTCCACTCCTTCC 
Recombined 
allele 341 bp 
Nrl ISH probe, F 
Nrl ISH probe, R 
GAATGGCTTTCCCTCCCAGTCCC 
GGACATGCTGGGCTCCTGTCTC 
381 bp 
Nr2e3 ISH probe, F 
Nr2e3 ISH probe, R 
ATGAGCTCTACAGTGGCTG 
CTAGTTTTTGAACATGTCACACAGG 
1188 bp 
Gnat2 ISH probe, F 
Gnat2 ISH probe, R 
ATGGGGAGTGGCATCAGTG 
TTAAAAGAGCCCACAGTCCTTGAG 
1065 bp 
Pde6c ISH probe, F 
Pde6c ISH probe, R 
TTGTTGCTGTCGCACTAAGG 
TGACAGGACGGTACCCTTTC 
1023 bp 
Rho bisulfite, F 
Rho bisulfite, R 
AGTGAATTTAGGGTTTAAAGGTTTT 
CTACCAACATAAAAAACTACCATAATTC 
500 bp 
Opn1sw bisulfite, F 
Opn1sw bisulfite, R 
TTAATTGTATTTTTAAAGGAGGGTGTT 
CTCTCTCTAACCCAAATTACCTTCA 
477 bp 
Scrambled RNAi, S 
 
Scrambled RNAi, AS 
GTCGGCTCGTCGTAGAATGTGAAGCTTG- 
  ACATTCTACGACGAGCCGACCTTTTTG 
AATTCAAAAAGGTCGGCTCGTCGTAGAATGT- 
  CAAGCTTCACATTCTACGACGAGCCGAC 
N/A 
 
Table 3.1:  Oligonucleotides used in this study. 
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CHAPTER 4 
 
 
Summary and future directions 
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4.1 Summary 
 
This thesis has elucidated the regulation of the mouse rod photoreceptor determinant Nrl, 
as well as the consequences of acute Nrl knockout in the differentiated retina.  In this 
chapter, I will summarize the major findings, discuss topics for future research, and 
propose an experimental assay that might be useful in the continued study of rod-to-cone 
reprogramming. 
 
Transcriptional regulation of Nrl 
Experiments discussed in Chapter 2 demonstrated that Nrl expression is directly 
regulated by the transcription factors Crx, Otx2, and RORβ.  These factors bind to 
discrete sites within a phylogenetically conserved, 30-base pair region in the Nrl 
promoter.  Mutation of these sites is sufficient to abolish Nrl promoter activity in mouse 
retinal explants electroporated with fluorescent reporter constructs.  Moreover, 
quantitative RT-PCR in wild-type and Crx-/- retinas, as well as Otx2 and Crx knockdown 
experiments in retinal explants, suggest that Otx2 and Crx coordinately regulate Nrl 
during early retinal development.  In adult retinas, however, Nrl expression is likely 
maintained mostly by Crx and possibly by RORβ. 
 These results are significant because they establish a direct regulatory connection 
between Nrl and known mediators of photoreceptor differentiation.  Additionally, the 
identification of a critical cis-regulatory region may facilitate the correlation of human 
mutations in this region with retinal disease. 
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Partial reprogramming of rod photoreceptors into cones 
The hypotheses tested in Chapter 3 were based on the observation that Nrl is a 
developmental cell fate switch:  photoreceptor precursors that turn on Nrl become rods, 
while those that do not become cones.  First, we hypothesized that acute knockout of Nrl 
in adult rod photoreceptors would trigger transdifferentiation into cones.  Experiments 
performed in a drug-inducible Nrl knockout mouse showed that rod photoreceptors did, 
in fact, acquire some cone-like molecular, morphological, and functional features upon 
acute Nrl knockout.  However, rod-to-cone reprogramming was incomplete, possibly due 
to developmentally established epigenetic barriers such as DNA methylation. 
 Second, we hypothesized that partial reprogramming of rods into cones would 
rescue retinal degeneration caused by mutations in rod-enriched genes.  Specifically, we 
reasoned that converting diseased rods into cone-like cells would prevent primary rod 
photoreceptor death, thus circumventing secondary death of endogenous cones.  Acute 
Nrl knockout in the Rho-/- model of retinitis pigmentosa did indeed prevent rod cell death, 
and cone function was preserved.  This result is significant because it suggests that acute 
Nrl knockdown may represent a novel, widely applicable therapy for a subset of retinal 
diseases. 
 
4.2 Future directions 
 
This body of work has clarified certain aspects of Nrl regulation and the plasticity of 
photoreceptor identity, but many interesting questions remain.  Here, I review key 
avenues for future research within the topics addressed by this thesis. 
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The initiation of Nrl expression in photoreceptor precursors 
Despite the identification of Nrl transcriptional regulators by this thesis research and by 
other investigators (Kautzmann et al., 2011), the factors that promote initial Nrl 
expression specifically in rod photoreceptor precursors remain unknown.  There are 
numerous models that could potentially account for the rod-versus-cone fate decision.  
For example, dynamic environmental factors during development may predispose later-
born photoreceptor precursors to activate transcription of Nrl.  Alternatively, early 
expression of both Nrl and an unknown, antagonistic transcription factor may establish a 
bistable state in photoreceptor precursors via mutual inhibition.  Slight perturbation of 
this state could then induce dominance of one transcription factor over the other, resulting 
in commitment to either the rod or cone fate (Zhou and Huang, 2011). 
 Elucidation of the specific mechanism whereby rod and cone precursors diverge 
may require difficult experiments such as transcriptome analysis of retinal progenitor 
cells, or identification of Nrl cis-regulatory elements that directly respond to diffusible 
factors present in the developing retina. 
 
Prospects for complete rod-to-cone reprogramming and functional implications 
Interestingly, Nrl deletion during adulthood only partially recapitulated the 
developmental knockout phenotype of rod-to-cone fate switching.  This prompts an 
important question:  is it even possible to induce full conversion of adult rod 
photoreceptors into cones at the molecular, morphological, and functional levels? 
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 Numerous examples of somatic cell reprogramming (discussed in Chapter 1) 
engender optimism for complete photoreceptor transdifferentiation under appropriate 
experimental conditions.  These conditions may need to be determined empirically; in 
most cases of successful reprogramming, investigators initially overexpressed large pools 
of factors in cells, then gradually narrowed down the pools to those factors essential for 
reprogramming (Ieda et al., 2010; Vierbuchen et al., 2010; Zhou et al., 2008).  The next 
section of this chapter describes an assay that could be used to determine sets of factors 
that promote complete reprogramming of rod photoreceptors into cones. 
 If full rod-to-cone conversion does prove possible, then this system could provide 
powerful insights into the functional consequences of a change in cellular identity.  
Interestingly, the cone photoreceptors of the Nrl-/- mouse have been shown to synapse on 
rod bipolar cells, which then connect normally to AII amacrine cells (Strettoi et al., 
2004).  This suggests that reprogramming of adult mouse rods into cones may not 
necessarily be accompanied by synaptic remodeling in the outer plexiform layer.  
However, it would be interesting to determine whether rod-to-cone conversion triggers 
remodeling of other retinal cell types and their connections, which has been observed 
under conditions such as retinal detachment and photoreceptor degeneration (reviewed in 
Fisher et al., 2005; Jones and Marc, 2005).   
 Another important question concerns visual function in animals with 
photoreceptor reprogramming:  would the animals be able to correctly process visual 
information originating from the neo-cones?  Electroretinography can detect changes in 
retinal currents, such as increased responsiveness to short-wavelength light due to S-cone 
gain-of-function (Mears et al., 2001).  It may be difficult to evaluate cone gain-of-
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function phenotypes using behavioral assays that test higher-order visual processing, such 
as the optokinetic reflex and two-alternative, forced-choice visual discrimination task 
(Cahill and Nathans, 2008; Prusky et al., 2000).  However, the successful integration of 
light information from reprogrammed cones would bode well for patients with cone-
dominant retinal disease, such as macular degeneration.  In these patients, the 
reprogramming of relatively healthy rods into functional cones may restore daylight and 
possibly high-acuity vision, depending on the extent of inner retina remodeling. 
 
4.3   An experimental assay for determining combinations of factors that result in 
complete rod-to-cone reprogramming 
 
Since knockdown of a single transcription factor, Nrl, is insufficient to cause complete 
rod-to-cone conversion, an assay may be required to identify additional factors required 
for full photoreceptor reprogramming.  Such an assay must satisfy several criteria to be 
effective.  First, it should be relatively high-throughput such that multiple conditions 
could be tested in a given experiment.  Second, it must accommodate the simultaneous 
expression of many different factors in individual cells.  Third, it should allow for both 
transient and constitutive expression of specific factors.  For example, initial but not 
prolonged expression of X or Y may promote rod-to-cone reprogramming, while factor Z 
might require continuous expression for the maintenance of cone identity.  Lastly, the 
assay must have a clear readout for reprogramming success or failure. 
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Experimental outline 
Here, I propose an in vivo electroporation assay that satisfies these requirements (Fig. 
4.1).  This assay utilizes two different protein expression methods:  the doxycycline-
inducible Tet-On 3G® system (Clontech) for transient factor expression, and a drug-
inducible Cre recombination system for permanent factor expression.  Tet-On 3G 
employs a constitutively expressed Tet transactivator that activates the TRE3G promoter 
only when bound to doxycycline.  Factors under control of the TRE3G promoter, 
therefore, will be transcribed only upon the administration of doxycycline.  ERT2-Cre-
ERT2, on the other hand, is a constitutively expressed Cre recombinase that translocates 
to the nucleus only when bound to 4-hydroxytamoxifen (4-OHT).  Factors are subcloned 
into a vector containing a floxed transcriptional stop cassette, pNrl-loxP-STOP-loxP-
[Factor].  Upon Cre activation by 4-OHT, the stop cassette is permanently removed and 
the factor is transcribed continuously under the control of the Nrl promoter.  Cre 
activation will also induce recombination of genomic floxed Nrl alleles in the Nrlf/f 
mouse, which is important since Nrl knockout likely is required for the induction and 
maintenance of cone identity.   
 All DNA plasmids described here (and summarized in Fig. 4.1) must be 
electroporated into the retinas of Nrlf/f P0 mouse pups for efficient uptake into 
photoreceptor nuclei.  In vivo electroporation is a well-established method for 
transduction of retinal cells, and individual cells have been shown to co-express multiple 
electroporated constructs (de Melo and Blackshaw, 2011; Matsuda and Cepko, 2004, 
2007, 2008).  Certain factors including the Tet transactivator, drug-inducible Cre, and 
fluorescent electroporation control will be expressed immediately in rod precursors under 
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the control of the 3.2-kb mouse Nrl promoter.  The reprogramming factors, however, will 
not be expressed until mice are treated with doxycycline or 4-OHT at a later timepoint.  
Doxycycline can be injected intraperitoneally (IP) or incorporated into mouse chow and 
water.  Expression of the transient factors will commence upon initiation of doxycycline 
treatment and cease upon drug termination and clearance.  4-OHT or tamoxifen is usually 
injected IP, and several consecutive days of treatment may be required to induce 
sufficient recombination of reprogramming factor plasmids and the genomic Nrl alleles 
(see Chapter 3.9 for details). 
 After expression of the reprogramming factors for a period of time (which may 
require optimization), the mouse must be sacrificed and examined for evidence of rod-to-
cone transdifferentiation.  One possible readout is in situ hybridization for the S-opsin 
gene Opn1sw.  Electroporated regions can be identified in retinal cross-sections by 
expression of a fluorescent construct such as pNrl-dsRed.  If these regions also appear to 
exhibit derepression of Opn1sw, then reprogramming may have been successful.  A 
caveat is that electroporation transduces only a fraction of cells in the ONL, so Opn1sw 
derepression may be sparse.  However, the presence of Opn1sw in unusual locations, 
such as the inner half of the ONL and the dorsal retina, may represent ectopic expression 
induced by electroporated reprogramming factors.  Another potential readout is 
fluorescent antibody staining with a marker that labels cone cell bodies, such as cone 
arrestin.  Positive cone arrestin staining in an electroporated, pNrl-dsRed-positive cell 
strongly suggests conversion of a rod into a cone, since the Nrl promoter is active in rods 
and Nrl mutant cones but not in endogenous cones (Akimoto et al., 2006). 
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Potential pitfalls, controls, and preliminary data 
The proposed assay is subject to several potential pitfalls.  First, reprogramming factor 
expression may be too low to influence cell fate.  Second, ‘leaky’ factor expression prior 
to drug administration might confound the results:  factors that promote cone induction at 
an early developmental stage (e.g., P0-P14) may not necessarily effect rod-to-cone 
reprogramming in fully differentiated rods.  Third, normal retinal development might be 
impaired by trauma resulting from P0 in vivo electroporation and/or by constitutive 
expression of the Tet transactivator and Cre recombinase.  Fourth, the drugs used to 
induce factor expression, doxycycline and 4-OHT, might be toxic to photoreceptors 
(although we observed no obvious 4-OHT-related toxicity in the reprogramming 
experiments described in Chapter 3). 
 Several of these pitfalls may be circumvented by the inclusion of appropriate 
controls, including (1) electroporation of all DNA constructs but treatment with vehicle 
instead of drugs, (2) electroporation of the reprogramming factors but not the Tet 
transactivator and Cre recombinase, followed by treatment with drugs, and (3) 
electroporation of all DNA constructs and treatment with drugs in wild-type mice instead 
of Nrlf/f mice.  Additionally, preliminary testing of this assay in mouse retinal explants 
suggests that the Tet-On and Cre induction systems are tightly regulated with minimal 
factor expression in the absence of doxycycline or 4-OHT (Fig. 4.2).  In contrast, 
expression is robust following the administration of either doxycycline to induce GFP 
(Fig. 4.2A) or 4-OHT to induce DsRed (Fig. 4.2B).  This pilot experiment, with drug-
induced expression of fluorescent proteins, should be replicated in vivo prior to the 
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testing of actual reprogramming factors.  Candidate factors that may promote rod-to-cone 
transdifferentiation are listed in Table 4.1. 
 
Future directions 
After a successful reprogramming factor ‘cocktail’ has been identified, the result should 
be validated by other methods.  For example, the factors could be delivered to the adult 
mouse retina in vivo via adeno-associated virus (AAV), which would result in much more 
widespread transduction than electroporation.  Also, if reprogramming requires only a 
small number of factors, it may be feasible to create a transgenic mouse line that 
expresses the factors in a drug-inducible manner.  The latter strategy may be particularly 
useful if the reprogrammed mouse is to be subjected to visual function analyses, 
including electroretinography, optokinetic reflex testing, and electrophysiological 
recording from retinal cells. 
 
4.4 Materials and methods 
 
DNA constructs 
The pCAG-stop-DsRed construct has been described previously (‘pCALNL-DsRed’; 
Matsuda and Cepko, 2007).  To create pRho(2.2 kb)-GFP, the GFP coding sequence from 
pCAG-GFP (Matsuda and Cepko, 2004) was cloned in place of DsRed in the pRho(2.2 
kb)-DsRed vector (Matsuda and Cepko, 2004) using the EcoRI and NotI restriction sites.  
To create pCrx-ERT2-Cre-ERT2, the Crx promoter (kind gift from Connie Myers) was 
cloned in place of the CAG promoter in the pCAG-ERT2-Cre-ERT2 vector (Matsuda and 
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Cepko, 2007) using the SmaI and NotI restriction sites.  To create pNrl(3.2 kb)-Tet3G, 
the Tet3G coding sequence was isolated from pCMV-Tet3G (Clontech) using the BamHI 
(blunted) and SacII restriction sites.  Tet3G was ligated into the pNrl(3.2 kb)-DsRed 
vector (Matsuda and Cepko, 2004) in place of DsRed, which was removed by digestion 
with NotI (blunted) and SacII.  To create pTRE3G-GFP, GFP was isolated from pCAG-
GFP by PCR with the addition of 5’ SalI and 3’ BglII restriction sites.  These sites were 
used to insert GFP upstream of the IRES in the pTRE3G-IRES vector (Clontech).   
 
Electroporation and culture of explanted retinas 
Electroporation and explant culture of cd1 mouse retinas were performed as described 
previously (Hsiau et al., 2007) with the following exceptions.  First, each DNA construct 
for electroporation was suspended in PBS at a concentration of 0.5 μg/μl for the 
doxycycline induction experiment and 1 μg/μl for the 4-OHT induction experiment.  
Second, doxycycline was added to the culture medium of experimental wells the day after 
electroporation (P1), at a final concentration of 1 ng/μl (1.5 μl of a 2 mg/ml stock was 
added to 3 ml culture medium).  The medium and doxycycline were refreshed at P5, and 
explants were fixed at P8.  Third, 4-OHT was added to the culture medium of 
experimental wells on the day of electroporation (P0), at a final concentration of 100 nM 
(3 μl of a 100 μM stock was added to 3 ml culture medium).  The medium and 4-OHT 
were refreshed daily for two more days (P1 and P2), and explants were fixed at P8. 
 Figure 4.1:  Scheme for testing combinations of candidate photoreceptor 
reprogramming factors in vivo.  All DNA plasmid constructs, including the fluorescent 
electroporation control(s), Tet transactivator, 4-hydroxytamoxifen (4-OHT)-inducible Cre 
recombinase, and reprogramming factors, must be electroporated into the Nrlf/f mouse 
retina at postnatal day 0 (P0).  The reprogramming factors will not be transcribed until 
the mouse is treated with doxycycline to activate factors transiently or with 4-OHT to 
activate factors constitutively.  4-OHT will also trigger recombination of the genomic 
floxed Nrl alleles.  Successful rod-to-cone reprogramming may be evaluated via in situ 
hybridization for Opn1sw. 
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 Figure 4.2:  Protein expression is inducible by doxycycline and 4-OHT in mouse 
retinal explants.  (A) P0 mouse retinas were electroporated with the Tet transactivator 
(Tet3G) driven by the 3.2-kb mouse Nrl promoter and with GFP driven by a modified 
tetracycline response element.  Retinas were grown in explant culture, and doxycycline 
was added to experimental cultures at P1 and P5 to induce GFP expression.  By P8, GFP 
was strongly expressed in the ONL of the doxycycline-treated retinas but not the controls.  
(B) P0 mouse retinas were electroporated with (1) a control GFP construct driven by the 
2.2-kb bovine Rho promoter, (2) a DsRed construct under control of the CAG promoter 
following Cre-mediated recombination of a transcriptional stop cassette, and (3) a 4-
OHT-inducible Cre recombinase driven by a promoter extracted from the mouse Crx 
locus.  The electroporated explants were treated with 100 nM 4-OHT from P0-P2 and 
grown in culture until P8.  DsRed was expressed in 4-OHT-treated retinas but not 
controls. 
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Factor name Function Expression 
NeuroD1 Promotion of photoreceptor cell fate (Morrow et al., 
1999; Yan and Wang, 2004) 
Transient 
Otx2 Promotion of photoreceptor cell fate; activation of 
photoreceptor gene expression (Muranishi et al., 2011; 
Nishida et al., 2003) 
Transient 
Crx Direct regulation of most rod and cone genes (Chen et 
al., 1997; Corbo et al., 2010; Furukawa et al., 1997) 
Transient 
Thrb (TRβ2) Activation of Opn1mw expression in cones (Ng et al., 
2001) 
Constitutive 
Sall3 Activation of Opn1sw expression in cones (de Melo et 
al., 2011) 
Constitutive 
Rorb (RORβ) Direct regulation of Opn1sw (Srinivas et al., 2006) Constitutive 
Rora (RORα) Direct regulation of Opn1sw, Opn1mw, and Arr3 
(Fujieda et al., 2009) 
Constitutive 
Tet1 Promotion of DNA demethylation by conversion of 5-
methylcytosine to 5-hydroxymethylcytosine (Guo et al., 
2011) 
Transient 
Aicda (AID) Demethylation of 5-hydroxymethylcytosine (Fritz and 
Papavasiliou, 2010; Guo et al., 2011) 
Transient 
 
Table 4.1:  Candidate factors for rod-to-cone reprogramming.  The column on the 
right represents an educated guess, based on the factor’s known function or expression 
pattern, about whether the factor should be expressed transiently or constitutively. 
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